CS_SI_Final_Rev1.pdf

Size: px
Start display at page:

Download "CS_SI_Final_Rev1.pdf"

Transcription

1 Supporting Information Stereoretentive C(sp 3 ) S Cross-Coupling Feng Zhu, a# Eric Miller, a# Shuo-qing Zhang, b Duk Yi, a Sloane O Neill, a Xin Hong, b * Maciej A. Walczak a * a Department of Chemistry, University of Colorado, Boulder, CO 80309, United States b Department of Chemistry, Zhejiang University, Hangzhou, Zhejiang , P. R. China *hxchem@zju.edu.cn *maciej.walczak@colorado.edu S1

2 Table of Contents 1. General Information... S3 2. General Procedures... S4 3. Detailed Experimental Procedures for Compounds S4 4. Detailed Experimental Procedures for Compounds S1-S31... S28 5. Detailed Procedure for Protecting Group Removal... S43 6. Procedures for Mechanistic Studies... S43 7. Computational Details... S44 8. Additional Computational Results... S45 9. Cartesian Coordinates of Optimized Structures... S References... S Copies of 1D and 2D NMR Spectra... S121 S2

3 All chemicals were purchased as reagent grade and used without further purification unless otherwise noted. Solvents were filtered through a column of activated alumina prior to use. All reactions were carried out under anhydrous N2 in oven-dried glassware. m-xylene was distilled under nitrogen over sodium and degassed prior to use. Anhydrous 1,4-dioxane, Anhydrous 1,2-dichloroethane, JackiePhos, and CuCl were purchased from Sigma-Aldrich. Anhydrous KF was purchased from Strem Chemicals, Inc. Visualizations were performed with UV light and/or Hanessian stain and/or sulfuric acid stain (5% H2SO4 in MeOH). Column chromatography was performed on silica gel ( mesh). 1 H and 13 C NMR spectra were recorded on Bruker/Varian 300/400/500 MHz instruments and are reported as follows: chemical shift (δ), multiplicity (s = singlet, d = doublet, t = triplet, q =quartet, br = broad, m = multiplet), coupling constants (Hz), and integration. The residual solvent reference peaks were used from published literature. 2D NMR experiments were performed using standard parameters (200 and More NMR Experiments, S. Berger, S. Braun, Wiley-VCH, 2004). IR measurements were performed on Agilent Cary 630 FT/IR instrument and optical rotations were measured on JASCO P-1030 and are reported as average of five data points. High-resolution mass spectra (HR-MS) were recorded on a Waters Synapt G2 HDMS q-tof hybrid mass spectrometer. S3

4 General Procedure A for Cross-Coupling Reactions Anomeric stannane ( equiv), disulfide (1.00 equiv), and CuCl (300 mol%) were added to a one dram vial with a screw-top septum, and the vial was then evacuated and refilled with N2 (3x). Anhydrous m- xylene and 1,2-dichloroethane (2:1, 3.00 ml) were added and the reaction mixture was heated in an oil bath (130 o C) for the indicated period of time, cooled to rt, filtered through a pad of Celite, and concentrated. 1 H NMR spectra were recorded using this mixture to evaluate diastereoselectivity. The crude material was purified by column chromatography on SiO2. General Procedure B for Cross-Coupling Reactions Anomeric stannane ( equiv), succinimide (1.00 equiv), and CuCl (300 mol%) were added to a one dram vial with a screw-top septum, and the vial was then evacuated and refilled with N2 (3x). Anhydrous m- xylene and 1,2-dichloroethane (2:1, 3.00 ml) were added and the reaction mixture was heated in an oil bath (110 or 130 o C) for the indicated period of time, cooled to rt, filtered through a pad of Celite, and concentrated. 1 H NMR spectra were recorded using this mixture to evaluate diastereoselectivity. The crude material was purified by column chromatography on SiO2. General Procedure C for the Preparation of Disulfanes Sodium perborate monohydrate (2.00 equiv.) was added to a stirring solution of aromatic thiol (1.00 equiv.) in a 2.5:1 AcOH/H2O solution (0.250 M). The resulting solution was stirred at ambient temperature for 4 hours. The crude mixture was concentrated in vacuo and purified via flash chromatography on silica. General Procedure D for Preparation of N-thio-pyrrolidine-2,5-diones To a flame-dried round bottom flask was charged N-chlorosuccinimide (1.05 equiv.) and anhydrous CH2Cl2 (0.250 M). The mixture was cooled to 0 C and aliphatic or aromatic thiol (1.00 equiv.) in anhydrous CH2Cl2 (1.00 M) was added dropwise via syringe pump over minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (1.10 equiv.) in CH2Cl2 (1.00 M) via syringe pump over minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried, filtered, and concentrated. The crude material was purified via flash chromatography on silica. Phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (10). 1 According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 1,2- diphenyldisulfane (21.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m- xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 10:1) 10 (45.6 mg, 72%) as a white solid: = +6.9 (c = 0.40, CHCl3); IR (ATR) ν = 3030, 2862, 1477, 1359, 1278, 1066, 909, 735, 696 cm - 1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 18H), (m, 5H), S4

5 (m, 4H), 4.74 (d, J = 10.3 Hz, 1H), 4.68 (d, J = 9.7 Hz, 1H), (m, 3H), (m, 4H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 138.6, 138.5, 138.2, 134.0, 132.1, 129.0, (2), 128.5, 128.4, 128.1, 128.0, 127.9, (2), 127.7, 127.6, 87.6, 86.9, 81.0, 79.3, 78.0, 76.0, 75.6, 75.2, 73.6, 69.2; HRMS (ESI) m/z calcd for C40H40O5SNa [M + Na] , found Fluorophenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (14). 3 According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol 1,2-bis(4- fluorophenyl)disulfane S1 (25.4 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 14 (47.5 mg, 73%) as a white foam: = +5.7 (c = 0.35, CHCl3); IR (ATR) ν = 3030, 2863, 1588, 1490, 1453, 1359, 1223, 1066, 909, 832, 735, 697 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 18H), 7.19 (dd, J = 7.1, 2.5 Hz, 2H), (m, 2H), (m, 4H), 4.75 (d, J = 10.3 Hz, 1H), (m, 4H), (m, 3H), 3.63 (t, J = 9.1 Hz, 1H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 138.5, 138.4, 138.2, 138.1, 135.0, 134.8, 128.6, 128.6, 128.5, 128.3, (2), 128.0, (2), 127.8, 116.2, 115.9, 87.8, 86.9, 81.0, 79.1, 77.9, 76.0, 75.6, 75.2, 73.6, 69.2; 19 F NMR (282 MHz, CDCl3) δ ; HRMS (ESI) m/z calcd for C40H39O5SFNa [M + Na] , found Methylphenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (15). 4 According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 1,2- bis(4-methylphenyl)disulfane (24.6 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 15 (45.3 mg, 70%) as a yellow solid. Characterization data matched the literature report. 4 4-(tert-Butyl)phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (16). According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol 1,2-bis(4- (tert-butyl)phenyl)disulfane S2 (33.0 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 16 (59.2 mg, 86%) as a colorless oil: = +2.9 (c = 1.00, CHCl3); IR (ATR) ν = 3029, 2956, 2864, 1488, 1453, 1359, 1268, 1208, 1063, 908, 829, 733, 696, 614 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 18H), (m, 4H), (m, 4H), 4.69 (d, J = 10.3 Hz, 1H), (m, 4H), (m, S5

6 4H), (m, 2H), 1.25 (s, 9H); 13 C NMR (75 MHz, CDCl3) δ 150.8, 138.5, 138.3, 138.2, 132.2, 130.2, (2), (3), 128.4, 128.1, (3), (2), 127.8, 127.7, 126.1, 87.7, 86.9, 80.9, 79.2, 78.0, 76.0, 75.5, 75.2, 73.6, 69.3, 34.7, 31.4; HRMS (ESI) m/z calcd for C44H48O5SNa [M + Na] , found (Acetylamino)phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (17). 3 According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), N,N'-(disulfanediylbis(4,1-phenylene))diacetamide S3 (33.2 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 1:1) 17 (56.5 mg, 82%) as a white foam: = -5.3 (c = 0.75, CHCl3); IR (ATR) ν = 3281, 3030, 1657, 1591, 1525, 1525, 1453, 1395, 1358, 1312, 1064, 908, 821, 735 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 20H), 7.19 (m, 3H), (m, 4H), 4.74 (d, J = 10.3 Hz, 1H), (m, 4H), (m, 4H), (m, 2H), 2.16 (s, 3H); 13 C NMR (75 MHz, CDCl3) δ 168.3, 138.5, 138.4, 138.2, 137.8, 133.7, (2), 128.5, 128.3, 128.1, 128.0, (2), (2), 127.7, 120.1, 87.8, 86.9, 81.0, 79.2, 77.9, 75.9, 75.5, 75.2, 73.5, 69.1, 24.8; HRMS (ESI) m/z calcd for C42H43O6SNNa [M + Na] , found Methoxyphenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (18). 3 According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 1,2- bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 8:1) 18 (63.6 mg, 96%) as a colorless oil: = +2.3 (c = 0.25, CHCl3); IR (ATR) ν = 3028, 2861, 1590, 1492, 1453, 1358, 1284, 1244, 1062, 908, 827, 732, 695, 641 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 20H), (m, 2H), (m, 4H), 4.76 (d, J = 10.3 Hz, 1H), (m, 4H), (m, 7H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 159.9, 138.6, 138.5, 138.3, 138.2, 135.3, (2), 128.5, 128.3, 128.1, 128.0, (2), (2), 127.7, 123.6, 114.6, 88.0, 86.9, 80.9, 79.1, 78.0, 75.9, 75.5, 75.2, 73.6, 69.2, 55.4; HRMS (ESI) m/z calcd for C41H42O6SNa [M + Na] , found (Trifluoromethoxy)phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (19). According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), S6

7 1,2-bis(4-(trifluoromethoxy)phenyl)disulfane S5 (38.6 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 19 (40.0 mg, 56%) as a colorless oil: = (c = 0.70, CHCl3); IR (ATR) ν = 3031, 2865, 1490, 1453, 1255, 1207, 1160, 1063, 909, 844, 734, 695 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 18H), (m, 2H), (m, 2H), (m, 4H), 4.75 (d, J = 10.4 Hz, 1H), 4.65 (d, J = 9.7 Hz, 1H), (m, 3H), (m, 4H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 138.4, 138.3, 138.1, 138.0, 133.4, 132.6, (2), 128.5, 128.3, 128.1, 128.0, (2), (2), 121.4, 87.4, 86.8, 80.9, 79.2, 77.9, 76.0, 75.6, 75.2, 73.6, 69.2; 19 F NMR (282 MHz, CDCl3) δ -57.8; HRMS (ESI) m/z calcd for C41H39O6SF3Na [M + Na] , found Methoxyphenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (20). 3 According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 1-((3- methoxyphenyl)thio)pyrrolidine-2,5-dione S6 (23.7 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 8:1) 20 (33.1 mg, 50%) as a colorless oil: = -1.0 (c = 0.90, CHCl3); IR (ATR) ν = 3030, 2863, 1588, 1453, 1359, 1248, 1065, 735, 696 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 18H), (m, 5H), (m, 1H), (m, 4H), 4.71 (dd, J = 12.2, 10.0 Hz, 2H), (m, 3H), (m, 7H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 159.9, 138.5, 138.3, (2), 135.2, 129.8, (2), (2), 128.3, 128.1, 128.0, (2), 127.8, 127.7, 124.0, 116.7, 113.9, 87.6, 86.9, 80.8, 79.3, 77.9, 76.0, 75.5, 75.2, 73.6, 69.2, 55.3; HRMS (ESI) m/z calcd for C41H42O6SNa [M + Na] , found ,5-Dimethylphenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (21). According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol, 1,2- bis(3,5-dimethylphenyl)disulfane S7 (38.6 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 21 (40.9 mg, 62%) as a colorless oil: = (c = 0.20, CHCl3); IR (ATR) ν = 3030, 2908, 2863, 1581, 1453, 1360, 1278, 1210, 1069, 909, 847, 736, 697 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 18H), (m, 4H), 6.86 (td, J = 1.6, 0.8 Hz, 1H), (m, 4H), 4.74 (d, J = 10.3 Hz, 1H), (m, 4H), (m, 4H), 3.51 (t, J = 9.1 Hz, 2H), 2.21 (s, 6H); 13 C NMR (75 MHz, CDCl3) δ 138.6, 138.6, 138.4, 138.3, 138.2, 133.4, 129.8, 129.5, 128.6, 128.6, 128.5, 128.5, 128.3, 128.1, 128.0, 128.0, 127.9, 127.9, 127.9, 127.8, 127.7, 87.9, 87.0, 81.1, 79.3, 78.0, 76.0, 75.5, 75.2, 73.6, 69.2, 21.3; HRMS (ESI) m/z calcd for C42H44O5SNa [M + Na] , found S7

8 3,4-Dimethoxyphenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (22). According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 1-((3,4- dimethoxyphenyl)thio)pyrrolidine-2,5-dione S8 (26.7 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 22 (41.5 mg, 60%) as a colorless oil: = -2.4 (c = 1.00, CHCl3); IR (ATR) ν = 3029, 2902, 1582, 1501, 1453, 1252, 1134, 1062, 1062, 909, 731, 695 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 18H), (m, 4H), 6.70 (d, J = 8.3 Hz, 1H), (m, 4H), 4.74 (d, J = 10.4 Hz, 1H), (m, 4H), 3.84 (s, 3H), (m, 3H), 3.66 (s, 3H), 3.63 (d, J = 9.0 Hz, 1H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 149.3, 149.0, 138.5, 138.3, (2), (3), 128.5, 128.2, 128.1, 128.0, 127.9, (2), 126.1, 124.1, 116.5, 111.4, 88.1, 87.0, 80.7, 79.1, 77.9, 75.9, 75.4, 75.2, 73.6, 69.3, 56.0, 55.9; HRMS (ESI) m/z calcd for C42H44O7SNa [M + Na] , found Naphthalenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (23). According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 1,2- di(naphthalen-2-yl)disulfane S9 (31.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 23 (49.9 mg, 73%) as a colorless foam: = +3.3 (c = 1.00, CHCl3); IR (ATR) ν = 3030, 2863, 1587, 1496, 1453, 1358, 1272, 1209, 1065, 908, 815, 734, 696 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ 8.10 (d, J = 1.4 Hz, 1H), (m, 1H), (m, 3H), (m, 20H), (m, 2H), (m, 4H), (m, 2H), (m, 3H), (m, 4H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 138.5, 138.4, (2), 133.8, 132.6, 131.2, 131.1, 129.6, 128.6, 128.5, 128.3, 128.2, 128.1, 128.0, (3), (2), 127.7, 126.6, 126.3, 87.6, 86.9, 81.0, 79.3, 78.0, 76.0, 75.6, 75.2, 73.6, 69.2; HRMS (ESI) m/z calcd for C44H42O5SNa [M + Na] , found iso-Propyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (24). 5 According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 2- (isopropylthio)isoindoline-1,3-dione S10 (22.1 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 24 (24.6 mg, 41%) as a white solid: = (c = 4.40, CHCl3); IR (ATR) ν = 3030, 2863, 1587, 1496, 1453, S8

9 1358, 1272, 1209, 1065, 908, 815, 734, 696 cm -1 ; 1 H NMR (300 MHz CDCl3) δ (m, 18H), (m, 2H), (m, 4H), 4.72 (d, J = 10.2 Hz, 1H), (m, 4H), (m, 3H), 3.59 (t, J = 9.2 Hz, 1H), (m, 2H), 3.25 (p, J = 6.7 Hz, 1H), 1.37 (d, J = 5.8 Hz, 3H), 1.35 (d, J = 5.7 Hz, 3H); 13 C NMR (75 MHz, CDCl3) δ 138.7, 138.4, 138.2, 128.6, (3), 128.1, (2), 127.8, 127.8, 127.7, 86.9, 84.8, 82.2, 79.2, 78.2, 75.9, 75.7, 75.2, 73.6, 69.4, 35.7, 24.2 (2); HRMS (ESI) m/z calcd for C37H42O5SNa [M + Na] , found Cyclohexyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (25). 6 According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 2- (cyclohexylthio)isoindoline-1,3-dione (26.1 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 25 (37.0 mg, 58%) as a white foam: = +4.5 (c = 0.35, CHCl3); IR (ATR) ν = 3029, 2925, 2851, 1496, 1450, 1357, 1264, 1207, 1063, 908, 818, 734, 696 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 18H), (m, 2H), (m, 2H), (m, 2H), 4.72 (d, J = 10.2 Hz, 1H), (m, 4H), (m, 3H), 3.58 (t, J = 9.2 Hz, 1H), (m, 2H), 3.00 (tt, J = 10.6, 3.7 Hz, 1H), 2.05 (d, J = 12.8 Hz, 2H), 1.76 (dd, J = 10.2, 3.7 Hz, 2H), 1.59 (s, 1H), (m, 2H), (m, 3H); 13 C NMR (75 MHz, CDCl3) δ 138.7, 138.4, 138.3, 138.2, 128.6, (3), 128.1, 127.9, 127.8, 127.7, 86.9, 84.6, 82.2, 79.2, 78.2, 75.9, 75.7, 75.2, 73.5, 69.5, 44.0, 34.4, 34.3, 26.3, 26.1, 25.9; HRMS (ESI) m/z calcd for C40H46O5SNa [M + Na] , found (2-(Boc-amino)ethyl) 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (26). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), tertbutyl-(2-((2,5-dioxopyrrolidin-1-yl)thio)ethyl)carbamate S11 (27.3 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 110 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 26 (46.9 mg, 67%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3373, 3030, 2905, 1708, 1497, 1453, 1363, 1248, 1160, 1063, 909, 732, 696 cm-1; 1H NMR (300 MHz, CDCl3) δ (m, 18H), (m, 2H), 5.40 (s, 1H), (m, 5H), (m, 3H), 4.44 (d, J = 9.7 Hz, 1H), (m, 4H), (m, 4H), 2.92 (dt, J = 14.0, 5.9 Hz, 1H), 2.78 (dt, J = 14.1, 6.0 Hz, 1H), 1.44 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 156.0, 138.6, 138.1, 138.1, 138.0, 128.6, 128.5, 128.4, 128.1, 128.0, 128.0, 128.0, 127.9, 127.8, 127.8, 86.7, 85.9, 81.6, 79.3, 78.9, 77.9, 75.9, 75.7, 75.2, 73.6, 69.1, 41.3, 32.3, 28.6; HRMS (ESI) m/z calcd for C41H49O7SNNa [M + Na] , found S9

10 2-((2-Ethylhexyl)oxycarbonyl)ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (26). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 2-ethylhexyl-3-((2,5-dioxopyrrolidin-1-yl)thio)propanoate S12 (31.5 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 110 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 27 (49.6 mg, 67%) as a colorless oil: = +2.2 (c = 1.00, CHCl3); IR (ATR) ν = 3030, 2927, 2861, 1732, 1454, 1359, 1279, 1131, 1064, 907, 733 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 18H), (m, 2H), 4.88 (qd, J = 10.9, 8.7 Hz, 4H), 4.75 (d, J = 10.3 Hz, 1H), (m, 3H), 4.49 (d, J = 9.7 Hz, 1H), (m, 2H), (m, 4H), (m, 2H), (m, 2H), (m, 2H), (m, 2H), (m, 7H), (m, 6H); 13 C NMR (75 MHz, CDCl3) δ 172.2, 138.6, 138.3, 138.2, 138.0, 128.6, (3), 128.4, 128.1, 128.0, (2), 127.8, 127.7, 86.7, 85.6, 81.8, 79.2, 78.0, 75.9, 75.6, 75.2, 73.6, 69.1, 67.3, 38.8, 35.8, 30.5, 29.0, 26.2, 23.9, 23.1, 14.2, 11.1; HRMS (ESI) m/z calcd for C45H56O7SNNa [M + Na] , found (R)-2,8-Dimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-6-(((2S,3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6- ((benzyloxy)methyl)tetrahydro-2h-pyran-2-yl)thio)chromane (28). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 1-(((R)-2,8- dimethyl-2-((4r,8r)-4,8,12-trimethyltridecyl)chroman-6-yl)thio)pyrrolidine-2,5-dione S13 (51.6 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4- dioxane (3.00 ml). The reaction mixture was heated under N2 at 110 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 15:1) 28 (64.0 mg, 68%) as a colorless oil: = (c = 11.0, CHCl3); IR (ATR) ν = 2925, 2866, 1458, 1363, 1223, 1070, 1033, 735, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 16H), (m, 4H), (m, 5H), (m, 4H), (m, 3H), (m, 1H), (m, 2H), 2.59 (t, J = 6.8 Hz, 2H), 2.07 (s, 3H), (m, 2H), (m, 23H), (m, 13H); 13 C NMR (75 MHz, CDCl3) δ 152.7, 138.6, (2), 138.3, 134.0, 132.8, 128.6, (2), 128.3, 128.1, 128.0, (2), 127.8, 127.7, 127.1, 121.2, 121.1, 88.6, 87.0, 81.1, 79.3, 78.0, 76.6, 76.0, 75.4, 75.1, 73.7, 69.3, 40.4, 39.5, 37.6, 37.4, 32.9 (2), 31.1, 28.1, 24.9, 24.6, 24.4, 22.9, 22.8, 22.2, 21.1, 19.9, 19.8, 16.1; HRMS (ESI) m/z calcd for C61H80O6SNa [M + Na] , found S10

11 4-Methoxyphenyl 2,3,4,6-tetra-O-benzyl-1-thio-α-D-glucopyranoside (33). According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 1,2- bis(4-methoxyphenyl)disulfide S5 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 8:1) 33 (58.3 mg, 88%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3029, 2863, 1591, 1493, 1453, 1360, 1285, 1245, 1071, 827, 734, 696 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 20H), (m, 2H), (m, 2H), 5.49 (d, J = 4.6 Hz, 1H), 5.03 (d, J = 10.9 Hz, 1H), (m, 3H), 4.71 (d, J = 11.7 Hz, 1H), (m, 2H), (m, 2H), (m, 2H), 3.78 (s, 4H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 159.6, 138.9, 138.4, 138.1, 137.9, 134.9, 128.6, 128.5, 128.4, 128.3, 128.1, (3), 127.8, (2), 124.5, 114.7, 88.1, 82.6, 80.0, 77.8, 75.9, 75.2, 73.5, 72.6, 71.2, 68.9, 55.4; HRMS (ESI) m/z calcd for C41H42O6SNa [M + Na] , found Methoxyphenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-galactopyranoside (34). According to the general protocol A, [2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl]tri-n-butylstannane 2 (122 mg, mmol), 1,2- bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 34 (74.0 mg, 91%) as a colorless oil: = +5.1 (c = 1.00, CHCl3); IR (ATR) ν = 3029, 2863, 1591, 1493, 1453, 1359, 1284, 1244, 1089, 827, 731, 696 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 20H), (m, 2H), 4.98 (d, J = 11.5 Hz, 1H), (m, 4H), 4.61 (d, J = 11.5 Hz, 1H), (m, 3H), 3.98 (d, J = 3.7 Hz, 1H), 3.88 (t, J = 9.4 Hz, 1H), 3.76 (s, 3H), (m, 2H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 159.6, 139.0, 138.6, 138.4, 138.1, 134.8, (2), 128.4, 128.3, 128.0, 127.9, (2), 127.7, 127.5, 124.2, 114.5, 88.5, 84.4, 77.5, 77.3, 75.7, 74.5, 73.7, 73.7, 72.8, 68.9, 55.4; HRMS (ESI) m/z calcd for C41H42O6SNa [M + Na] , found Methoxyphenyl 2,3,4,6-tetra-O-benzyl-1-thio-α-D-galactopyranoside (35). According to the general protocol A, [2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl]tri-n-butylstannane 2 (122 mg, mmol), 1,2- bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 35 (37.8 mg, 88%) as a colorless oil: = (c = 11.50, CHCl3); IR (ATR) ν = 3033, 2869, 1596, 1495, 1458, 1290, 1249, 1100, 1070, 832, 739, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 22H), (m, 2H), 5.54 (d, J = 5.4 Hz, 1H), 4.98 (d, J = 11.5 Hz, 1H), 4.90 (d, J = 11.8 Hz, 1H), (m, 3H), 4.60 (d, J = 11.5 Hz, 1H), 4.53 (td, J = 6.2, 1.3 Hz, 1H), (m, 2H), 4.35 (dd, J = 10.0, 5.4 Hz, 1H), 4.00 (dd, J = 3.0, 1.3 Hz, 1H), 3.84 (dd, J = 10.0, 2.9 Hz, 1H), 3.74 (s, 3H), 3.56 (d, J = 6.3 Hz, 2H); 13 C NMR (75 S11

12 MHz, CDCl3) δ 159.6, 138.9, 138.8, 138.4, 138.3, 135.1, (2), 128.4, 128.3, 128.1, (2), (3), 124.6, 114.6, 88.7, 79.6, 76.8, 75.5, 74.9, 73.6, 73.5, 72.7, 70.4, 69.3, 55.4; HRMS (ESI) m/z calcd for C41H42O6SNa [M + Na] , found Methoxyphenyl 2,3,4,6-tetra-O-benzyl-1-thio-α-D-mannopyranoside (36). According to the general protocol A, (2,3,4,5-tetra-O-benzyl-α-D-mannopyranosyl)tri-n-butylstannane (162 mg, mmol) S15, 1,2- bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 6:1) 36 (69.1 mg, 85%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3029, 2865, 1591, 1493, 1453, 1364, 1285, 1246, 1089, 1027, 828, 736, 697 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 22H), (m, 2H), 5.45 (d, J = 1.7 Hz, 1H), 4.93 (d, J = 10.9 Hz, 1H), (m, 8H), 4.35 (ddd, J = 9.7, 5.2, 2.2 Hz, 1H), (m, 2H), (m, 3H), 3.76 (s, 3H); 13 C NMR (75 MHz, CDCl3) δ 159.8, 138.6, 138.4, 138.1, 134.9, (3), 128.4, (2), 128.0, 127.9, (2), 127.8, 127.5, 126.6, 124.4, 114.7, 86.6, 80.3, 76.2, 75.3, 73.5, 72.8, 72.2, 72.0, 69.6, 55.5; HRMS (ESI) m/z calcd for C41H42O6SNa [M + Na] , found Methoxyphenyl 2,3,4-tri-O-benzyl-6-O-acetyl-1-thio-β-D-glucopyranoside (37). According to the general protocol A, (6-O-acetyl-2,3,4-tri-O-benzyl-β-D-glycopyranosyl)tri-n-butylstannane S16 (115 mg, mmol), 1,2-bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 37 (35.7 mg, 58%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3030, 2900, 1740, 1591, 1493, 1454, 1362, 1242, 1064, 909, 829, 734, 697, 642 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 15H), (m, 2H), (m, 2H), (m, 2H), 4.76 (d, J = 10.3 Hz, 1H), 4.58 (d, J = 10.8 Hz, 1H), 4.52 (d, J = 9.7 Hz, 1H), 4.37 (dd, J = 11.8, 1.5 Hz, 1H), (m, 1H), 3.81 (s, 3H), 3.71 (t, J = 8.8 Hz, 1H), (m, 3H), 2.06 (s, 3H); 13 C NMR (75 MHz, CDCl3) δ 170.8, 160.0, 138.4, 138.1, 137.8, 135.5, 128.7, (2), 128.3, (2), 128.1, 127.9, 123.4, 114.5, 88.2, 86.9, 81.0, 77.7, 77.0, 76.0, 75.6, 75.2, 63.4, 55.5, 21.0; HRMS (ESI) m/z calcd for C36H38O7SNa [M + Na] , found S12

13 4-Methoxyphenyl 2,3,4-tri-O-benzyl-6-O-pivaloyl-1-thio-β-D-glucopyranoside (38). According to the general protocol A, (2,3,4-tri-O-benzyl-6-O-pivaloyl-β-D-glucopyranosyl)tri-n-butylstannane S17 (121 mg, mmol), 1,2-bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 38 (55.2 mg, 84%) as a colorless oil: = -3.2 (c = 1.00, CHCl3); IR (ATR) ν = 3030, 2958, 1728, 1591, 1493, 1360, 1283, 1244, 1144, 1063, 908, 828, 731, 696 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 2H), (m, 13H), (m, 2H), (m, 4H), 4.76 (d, J = 10.3 Hz, 1H), 4.59 (d, J = 10.6 Hz, 1H), 4.55 (d, J = 9.7 Hz, 1H), 4.47 (dd, J = 11.9, 1.3 Hz, 1H), (m, 1H), 3.82 (s, 3H), (m, 1H), (m, 2H), (m, 1H), 1.27 (s, 9H); 13 C NMR (75 MHz, CDCl3) δ 178.2, 160.0, 138.3, 138.2, 137.7, 135.4, 128.7, (2), 128.2, (2), 128.0, 127.9, 123.3, 114.6, 87.9, 86.8, 80.7, 77.9, 77.2, 76.0, 75.5, 75.3, 63.2, 55.4, 39.0, 27.4; HRMS (ESI) m/z calcd for C39H44O7SNa [M + Na] , found Methoxyphenyl 2,3,4-tri-O-benzyl-6-O-tert-butyldiphenylsilyl-1-thio-β-D-glucopyranoside (39). According to the general protocol A, (2,3,4-tri-O-benzyl-6-O-tert-butyldiphenylsilyl-β-D-glucopyranosyl)trin-butylstannane 2 (144 mg, mmol), 1,2-bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 39 (61.6 mg, 76%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3029, 2928, 2855, 1591, 1492, 1454, 1359, 1284, 1244, 1066, 907, 825, 735, 696 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 4H), (m, 2H), (m, 19H), (m, 2H), (m, 2H), (m, 4H), 4.75 (d, J = 10.4 Hz, 1H), 4.68 (d, J = 10.7 Hz, 1H), 4.55 (d, J = 9.7 Hz, 1H), (m, 2H), (m, 1H), 3.74 (s, 3H), 3.70 (t, J = 8.8 Hz, 1H), 3.48 (dd, J = 9.7, 8.4 Hz, 1H), 3.35 (ddd, J = 9.3, 3.6, 1.9 Hz, 1H), 1.09 (s, 9H); 13 C NMR (75 MHz, CDCl3) δ 159.7, 138.5, 138.4, 138.3, 136.0, 135.8, 135.0, 133.6, 133.2, (2), (3), 128.3, 128.1, 128.0, (3), 127.8, 124.1, 114.8, 114.6, 88.3, 87.1, 80.9, 80.0, 76.1, 75.4, 75.2, 62.9, 55.4, 27.0, 19.5; HRMS (ESI) m/z calcd for C50H54O6SNa [M + Na] , found Methoxyphenyl 2,3,4-tri-O-benzyl-6-O-(4-methoxybenzyl)-1-thio-β-D-glucopyranoside (40). According to the general protocol A, (2,3,4-tri-O-benzyl-6-O-(4-methoxybenzyl)-β-D-glucopyranosyl)tri-nbutylstannane S18 (127 mg, mmol), 1,2-bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 40 (48.5 mg, 70%) as a white foam: = +3.1 (c = 1.00, CHCl3); IR (ATR) ν = 3030, 2903, 1591, 1512, 1454, 1359, 1246, 1175, 1067, 828, 737, 698 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 15H), (m, 2H), (m, 2H), (m, 2H), 4.93 S13

14 (m, 4H), 4.74 (d, J = 10.3 Hz, 1H), (m, 3H), 4.47 (d, J = 11.5 Hz, 1H), 3.80 (s, 3H), 3.77 (s, 3H), (m, 3H), 3.61 (t, J = 9.2 Hz, 1H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 159.9, 159.3, 138.6, 138.3, 138.2, 135.3, 130.6, 129.5, (2), 128.5, 128.3, 128.1, 128.0, (2), 127.8, 123.7, 114.6, 113.9, 88.1, 86.9, 80.9, 79.2, 78.0, 75.9, 75.5, 75.1, 73.2, 68.9, 55.4 (2); HRMS (ESI) m/z calcd for C42H44O7SNa [M + Na] , found Methoxyphenyl 2,3,4-tri-O-benzyl-6-O-(2-naphthylmethyl)-1-thio-β-D-glucopyranoside (41). According to the general protocol A, [2,3,4-tri-O-benzyl-6-O-(2-naphthylmethyl)-β-D-glycopyranosyl]tri-nbutylstannane 2 (129.6 mg, mmol), 1,2-bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 8:1) 41 (69.1 mg, 97%) as a colorless oil: = -4.2 (c = 1.00, CHCl3); IR (ATR) ν = 3029, 2862, 1591, 1492, 1454, 1358, 1284, 1244, 1063, 907, 817, 731, 696 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 4H), (m, 14H), (m, 6H), (m, 2H), (m, 7H), (m, 2H), (m, 4H), 3.56 (s, 3H), (m, 2H); 13 C NMR (75 MHz, CDCl3) δ 159.8, 138.5, 138.3, 138.1, 136.0, 135.2, 133.4, 133.1, 128.6, (2), 128.3, 128.2, 128.1, (2), (2), 127.8, 126.5, 126.2, (2), 123.6, 114.5, 88.0, 86.9, 80.9, 79.1, 78.0, 75.9, 75.5, 75.2, 73.7, 69.2, 55.2; HRMS (ESI) m/z calcd for C45H44O6SNa [M + Na] , found Methoxyphenyl 2-deoxy-3,4,6-tri-O-benzyl-1-thio-α-D-glucopyranoside (42). According to the general protocol B, (3,4,6-tri-O-benzyl-2-deoxy-β-D-glucopyranosyl)tri-n-butylstannane 2 (141 mg, mmol), 1- ((4-methoxyphenyl)thio)pyrrolidine-2,5-dione S14 (23.7 mg, mmol), JackiePhos (44.0 mg, mmol), KF (17.4 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 8:1) 42 (23.4 mg, 42%) as a colorless oil: = (c = 0.40, CHCl3); IR (ATR) ν = 3028, 2903, 1591, 1492, 1453, 1361, 1285, 1243, 1175, 1087, 1026, 827, 734, 696 cm - 1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 15H), (m, 2H), (m, 2H), 5.51 (d, J = 5.7 Hz, 1H), 4.91 (d, J = 10.9 Hz, 1H), (m, 2H), 4.61 (d, J = 12.0 Hz, 1H), (m, 1H), 4.46 (d, J = 12.0 Hz, 1H), 4.37 (ddd, J = 9.8, 4.6, 2.0 Hz, 1H), 3.98 (ddd, J = 11.7, 8.7, 4.9 Hz, 1H), (m, 1H), 3.76 (s, 3H), 3.70 (dd, J = 10.6, 2.0 Hz, 1H), 3.60 (dd, J = 9.9, 8.7 Hz, 1H), 2.45 (ddd, J = 13.3, 4.9, 1.3 Hz, 1H), 2.08 (ddd, J = 13.4, 11.6, 5.7 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 159.7, 138.6, 138.6, 138.4, 134.7, 128.6, 128.5, 128.4, 128.1, 128.0, 127.9, 127.8, 127.8, 127.7, 114.7, 85.1, 78.8, 78.0, 75.1, 73.6, 72.0, 71.7, 69.3, 55.4, 36.2; HRMS (ESI) m/z calcd for C34H36O5SNa [M + Na] , found S14

15 4-Methoxyphenyl 2-deoxy-3,4,6-tri-O-benzyl-1-thio-α-D-galactopyranoside (43). According to the general protocol B, (3,4,6-tri-O-benzyl-2-deoxy-β-D-galactopyranosyl)tri-n-butylstannane S19 (141.4 mg, mmol), 1-((4-methoxyphenyl)thio)pyrrolidine-2,5-dione S14 (23.7 mg, mmol), JackiePhos (44.0 mg, mmol), KF (17.4 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4- dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 43 (29.0 mg, 52%) as a white foam: = (c = 13.3, CHCl3); IR (ATR) ν = 3029, 2865, 1596, 1495, 1458, 1365, 1286, 1249, 1093, 1063, 1029, 832, 739, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 17H), (m, 2H), 5.56 (d, J = 6.3 Hz, 1H), 4.95 (d, J = 11.6 Hz, 1H), (m, 3H), 4.47 (dd, J = 11.0, 5.7 Hz, 3H), (m, 2H), 3.74 (s, 3H), (m, 2H), 2.59 (ddd, J = 12.9, 11.7, 5.7 Hz, 1H), (m, 1H); 13 C NMR (75 MHz, CDCl3) δ 159.6, 139.0, 138.4, 138.4, 134.7, 128.6, 128.5, 128.4, 128.2, (2), 127.7, 127.6, 127.5, 125.1, 114.7, 114.6, 85.5, 75.5, 74.5, 73.6, 73.5, 70.9, 70.7, 69.9, 55.4, 31.8; HRMS (ESI) m/z calcd for C34H36O5SNa [M + Na] , found Methoxyphenyl 2,3,4-tri-O-benzyl-1-thio-β-L-fucopyranoside (44). According to the general protocol A, (2,3,4-tri-O-benzyl-β-L-fucopyranosyl)tri-n-butylstannane S20 (106 mg, mmol), 1,2-bis(4- methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 8:1) 44 (29.5 mg, 53%) as a colorless oil: = -2.8 (c = 0.80, CHCl3); IR (ATR) ν = 3029, 2864, 1591, 1493, 1454, 1355, 1283, 1244, 1174, 1086, 1065, 909, 828, 730 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 15H), (m, 2H), 5.00 (d, J = 11.6 Hz, 1H), (m, 4H), 4.66 (d, J = 11.6 Hz, 1H), 4.49 (d, J = 9.6 Hz, 1H), 3.86 (t, J = 9.3 Hz, 1H), 3.76 (s, 3H), (m, 2H), (m, 1H), 1.26 (d, J = 6.4 Hz, 3H); 13 C NMR (75 MHz, CDCl3) δ 159.5, 138.9, 138.7, 138.5, 134.8, 128.6, (2), 128.3, 128.0, 127.8, 127.7, 127.6, 124.4, 114.4, 88.3, 84.8, 77.3, 76.8, 75.7, 74.7, 73.0, 55.4, 17.4; HRMS (ESI) m/z calcd for C34H36O5SNa [M + Na] , found Methoxyphenyl 2,3,4-tri-O-benzyl-1-thio-β-L-quivonopyranoside (45). According to the general protocol A, (2,3,4-tri-O-benzyl-β-L-quivopyranosyl)tri-n-butylstannane S21 (106 mg, mmol), 1,2- bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 S15

16 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 8:1) 45 (29.5 mg, 53%) as a colorless oil: = -8.1 (c = 0.80, CHCl3); IR (ATR) ν = 3030, 2898, 1591, 1492, 1453, 1358, 1284, 1244, 1173, 1065, 829, 735, 697 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 15H), (m, 2H), (m, 4H), 4.76 (d, J = 10.3 Hz, 1H), 4.65 (dd, J = 11.1, 2.3 Hz, 1H), 4.51 (d, J = 9.7 Hz, 1H), 3.81 (s, 3H), 3.66 (t, J = 8.9 Hz, 1H), (m, 2H), 3.20 (t, J = 9.2 Hz, 1H), 1.34 (d, J = 6.1 Hz, 3H); 13 C NMR (75 MHz, CDCl3) δ 159.9, 138.6, 138.3, 138.2, 135.3, (2), 128.3, 128.1, (2), 127.8, 123.9, 114.6, 88.3, 86.8, 83.5, 81.4, 75.9, 75.7, 75.5 (2), 55.5, 18.3; HRMS (ESI) m/z calcd for C34H36O5SNa [M + Na] , found Methoxyphenyl 2,3,4-tri-O-benzyl-1-thio-β-D-arabinopyranoside (46). According to the general protocol A, (2,3,4-tri-O-benzyl-β-D-arabinosyl)tri-n-butylstannane 2 (104 mg, mmol), 1,2-bis(4- methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 8:1) 46 (45.0 mg, 83%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3029, 2863, 1591, 1493, 1453, 1356, 1284, 1244, 1083, 1026, 908, 827, 731 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 15H), (m, 2H), (m, 6H), 4.61 (d, J = 12.2 Hz, 1H), 4.27 (dd, J = 12.1, 5.5 Hz, 1H), 3.90 (t, J = 6.7 Hz, 1H), (m, 4H), 3.67 (dd, J = 7.1, 3.1 Hz, 1H), 3.42 (dd, J = 12.1, 2.4 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 159.6, 138.4, 138.3, 134.6, (2), 128.2, (2), 127.8, 127.1, 114.6, 88.3, 79.2, 77.4, 74.4, 72.6, 72.4, 71.2, 63.1, 55.4; HRMS (ESI) m/z calcd for C33H34O5SNa [M + Na] , found Methoxyphenyl 2,3,6-tri-O-benzyl-4-O-[2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl]-1-thio-β-Dglucopyranoside (47). According to the general protocol A, [2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl- (1 4)-2,3,6-tri-O-benzyl-β-D-glucopyranosyl]tri-n-butylstannane S22 (171 mg, mmol), 1,2-bis(4- methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 7:1) 47 (71.2 mg, 72%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3030, 2863, 1591, 1493, 1453, 1359, 1245, 1056, 1041, 908, 731, 695 cm -1 ; 1 H NMR (400 MHz, CDCl3) δ (m, 2H), (m, 35H), (m, 2H), 5.58 (d, J = 3.7 Hz, 1H), (m, 4H), 4.72 (d, J = 10.6 Hz, 2H), (m, 7H), 4.37 (d, J = 10.8 Hz, 1H), 4.24 (d, J = 12.2 Hz, 1H), 4.02 (t, J = 9.3 Hz, 1H), (m, 2H), (m, 6H), 3.59 (dd, J = 10.1, 8.9 Hz, 1H), (m, 4H), 3.36 (dd, J = 10.7, 1.9 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 159.9, (2), 138.7, 138.5, (2), 135.4, (2), (4), 128.1, 128.0, 127.9, (2), (2), 127.6, 127.5, 127.3, 126.6, 123.4, 114.6, 97.2, 87.7, 86.9, 82.2, 81.0, 79.5, 78.8, 77.9, S16

17 75.6, 75.3, 75.1, 74.4, 73.6, 73.5, 73.4, 72.8, 71.2, 69.3, 68.4, 55.4; HRMS (ESI) m/z calcd for C68H70O11SNa [M + Na] , found Methoxyphenyl 2,3,6-tri-O-benzyl-4-O-[2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl]-1-thio-β-Dglucopyranoside (48). According to the general protocol A, [2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl- (1 4)-2,3,6-tri-O-benzyl-β-D-glucopyranosyl]tri-n-butylstannane 2 (171 mg, mmol), 1,2-bis(4- methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 6:1) 48 (65.2 mg, 66%) as a white foam: = -5.7 (c = 1.00, CHCl3); IR (ATR) ν = 3051, 3018, 2854, 1584, 1483, 1450, 1349, 1278, 1237, 1051, 906, 816, 727, 693 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 35H), (m, 2H), 5.10 (d, J = 10.5 Hz, 1H), 4.99 (d, J = 11.5 Hz, 1H), (m, 7H), (m, 6H), 4.25 (d, J = 11.8 Hz, 1H), (m, 8H), (m, 7H); 13 C NMR (75 MHz, CDCl3) δ 159.8, 139.2, 139.1, 138.9, 138.8, (2), 138.6, 138.2, 135.4, (3), (2), (2), 128.2, (2), 127.8, 127.7, (2), (2), 127.3, 123.5, 114.5, 103.0, 87.9, 85.2, 82.7, 80.1, 79.5, 76.6, 75.7, 75.5 (2), 74.9, 73.8, 73.5, 73.2, 72.8, 68.6, 68.2, 55.4; HRMS (ESI) m/z calcd for C68H70O11SNa [M + Na] , found Methoxyphenyl 3,4-di-O-benzyl-6-O-tert-butyldiphenylsilyl-2-O-[2,3,4,6-tetra-O-benzyl-β-Dglucopyranosyl]-1-thio-β-D-glucopyranoside (49). According to the general protocol A, [2,3,4,6-tetra-Obenzyl-β-D-glucopyranosyl-(1 2)-3,4-di-O-benzyl-6-O-tert-butyldiphenylsilyl-β-D-glucopyranosyl]tri-nbutylstannane S23 (207 mg, mmol), 1,2-bis(4-methoxyphenyl)disulfane S4 (27.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 9:1) 49 (82.1 mg, 66%) as a colorless oil: = -2.5 (c = 1.00, CHCl3); IR (ATR) ν = 3378, 3028, 1492, 1452, 1264, 1176, 1072, 1016, 905, 731, 649, 599 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 2H), (m, 2H), (m, 34H), (m, 2H), (m, 2H), (m, 3H), (m, 7H), (m, 3H), (m, 1H), (m, 3H), (m, 8H), (m, 2H), 3.36 (ddd, J = 11.2, 5.2, 2.9 Hz, 2H), 1.07 (s, 9H); 13 C NMR (75 MHz, CDCl3) δ 159.5, 138.9, 138.8, 138.7, 138.4, 138.3, 138.1, 136.0, 135.8, 135.1, 133.6, 133.2, (2), (2), (2), 128.4, (2), (2), (2), (2), 127.7, 127.6, 127.5, 124.8, 114.4, 102.4, 87.7, 87.2, 84.9, 82.9, 80.1, 78.1, 78.0, 75.9, 75.7, 75.6, 75.4, 75.3, 75.2, 75.1, 74.0, 68.9, 63.0, 55.4, 27.0, 19.4; HRMS (ESI) m/z calcd for C77H82O11SSiNa [M + Na] , found S17

18 Methyl 2,3,4-tri-O-benzyl-6-S-[2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl]-6-thio-α-Dglucopyranoside (51). 6 According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)trin-butylstannane 2 (122 mg, mmol), methyl 2,3,4-tri-O-benzyl-6-S-(pyrrolidine-2,5-dione)-6-thio-α-Dglucopyranoside S24 (47.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 51 (74.2 mg, 74%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3030, 2901, 1495, 1453, 1358, 1064, 907, 729 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 33H), (m, 2H), 5.00 (d, J = 10.9 Hz, 1H), (m, 8H), (m, 7H), (m, 1H), (m, 1H), (m, 4H), 3.53 (dd, J = 9.6, 3.6 Hz, 1H), (m, 6H), 3.11 (dd, J = 13.6, 2.5 Hz, 1H), 2.83 (dd, J = 13.6, 8.4 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 138.9, 138.7, 138.4, 138.3, (2), (2), (3), 128.4, 128.3, 128.2, 128.1, (2), (2), (2), (3), 97.9, 86.8, 85.8, 82.2, 82.1, 81.1, 80.1, 79.1, 78.0, 75.8, 75.6, 75.2, 75.1, 73.5, 73.4, 71.5, 69.1, 55.3, 32.3; HRMS (ESI) m/z calcd for C62H66O10SNa [M + Na] , found Methyl 2,3,4-tri-O-benzyl-6-S-[2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl]-6-thio-α-Dglucopyranoside (52). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-Dgalactopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), methyl 2,3,4-tri-O-benzyl-6-S-(pyrrolidine- 2,5-dione)-6-thio-α-D-glucopyranoside S24 (47.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 52 (88.3 mg, 88%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3030, 2906, 1495, 1453, 1359, 1207, 1087, 908, 732, 696 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 35H), (m, 2H), (m, 11H), 4.49 (d, J = 9.6 Hz, 1H), (m, 2H), (m, 3H), 3.81 (t, J = 9.4 Hz, 1H), (m, 4H), (m, 2H), 3.33 (s, 3H), (m, 1H), (m, 1H); 13 C NMR (75 MHz, CDCl3) δ 138.9, 138.8, 138.5, 138.4, 138.3, 138.2, 138.0, (2), (3), 128.4, (2), (2), (2), (2), 127.9, (2), (2), 127.6, 127.6, 97.8, 85.9, 84.2, 82.1, 81.0, 80.2, 78.8, 77.1, 75.8, 75.8, 75.1, 74.6, 73.6, 73.4, 72.7, 71.1, 68.6, 55.3, 31.9; HRMS (ESI) m/z calcd for C62H66O10SNa [M + Na] , found S18

19 Methyl 2,3,4-tri-O-benzyl-6-S-[2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl-(1 4)-2,3,6-tri-O-benzyl-β- D-glucopyranosyl]-6-thio-α-D-glucopyranoside (53). According to the general protocol B, [2,3,4,6-tetra-Obenzyl-α-D-glucopyranosyl-(1 4)-2,3,6-tri-O-benzyl-β-D-glucopyranosyl]tri-n-butylstannane S22 (171 mg, mmol), methyl 2,3,4-tri-O-benzyl-6-S-(pyrrolidine-2,5-dione)-6-thio-α-D-glucopyranoside S24 (47.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 53 (91.6 mg, 75%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3030, 2903, 1495, 1453, 1359, 1207, 1137, 1045, 1045, 908, 731, 696 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 50H), 5.66 (d, J = 3.6 Hz, 1H), 5.00 (dd, J = 10.9, 1.5 Hz, 1H), (m, 9H), (m, 11H), 4.33 (d, J = 12.2 Hz, 1H), 4.10 (t, J = 9.2 Hz, 1H), (m, 18H), (m, 1H), (m, 1H); 13 C NMR (75 MHz, CDCl3) δ (2), 138.8, (2), 138.3, (2), 138.1, 138.0, (3), (3), (2), (2), (4), (2), (2), (2), (3), (2), 127.5, 127.2, 126.6, 97.9, 97.1, 86.7, 85.5, 82.2 (2), 82.1, 81.2, 80.1, 79.5, 78.8, 77.9, 75.9, 75.8, 75.4, 75.3, 75.1, 74.2, 73.6, 73.5, 73.4 (2), 72.9, 71.7, 71.2, 69.3, 68.4, 55.3, 32.1; HRMS (ESI) m/z calcd for C89H94O15SNa [M + Na] , found Methyl 2,3,4-tri-O-benzyl-6-S-[2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl]-6-thio-α-Dglucopyranoside (54). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)trin-butylstannane 2 (122 mg, mmol), methyl 2,3,4-tri-O-benzyl-6-S-(pyrrolidine-2,5-dione)-6-thio-α-Dglucopyranoside S2 (47.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 54 (86.3 mg, 86%) as a colorless oil: = (c = 1.00, CHCl3); IR (ATR) ν = 3499, 3030, 2902, 1495, 1453, 1359, 1312, 1206, 1069, 908, 731 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 33H), (m, 2H), 5.61 (d, J = 4.7 Hz, 1H), (m, 8H), (m, 5H), 4.50 (d, J = 10.9 Hz, 1H), 4.42 (d, J = 12.0 Hz, 1H), 4.20 (ddd, J = 10.0, 3.6, 2.0 Hz, 1H), 4.03 (t, J = 9.2 Hz, 1H), (m, 3H), (m, 5H), 3.41 (s, 3H), 3.01 (dd, J = 13.9, 2.7 Hz, 1H), 2.73 (dd, J = 13.8, 6.5 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ (2), 138.5, 138.3, 138.2, 138.0, 137.9, 128.6, (3), (2), 128.2, 128.1, (2), (2), (2), (2), 127.1, 98.1, 83.8, 82.5, 82.0, 80.4, 80.2, 79.4, 77.5, 75.8, 75.7, 75.4, 75.1, 73.5, 72.0, 70.7, 70.3, 68.7, 65.4, 55.4, 30.5; HRMS (ESI) m/z calcd for C62H66O10SNa [M + Na] , found S19

20 Methyl 2,3,4-tri-O-benzyl-6-S-[3,4,6-tri-O-benzyl-2-deoxyl-α-D-glucopyranosyl]-6-thio-α-Dglucopyranoside (55). According to the general protocol B, (3,4,6-tri-O-benzyl-2-deoxy-β-Dglucopyranosyl)tri-n-butylstannane 2 (141.5 mg, mmol), methyl 2,3,4-tri-O-benzyl-6-S-(pyrrolidine- 2,5-dione)-6-thio-α-D-glucopyranoside S24 (47.1 mg, mmol), JackiePhos (44.0 mg, mmol), KF (17.8 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 55 (54.7 mg, 61%) as a colorless oil: = (c = 7.15, CHCl3); IR (ATR) ν = 3033, 2906, 2869, 1499, 1458, 1365, 1327,1089, 1052, 914, 735, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 30H), 5.48 (d, J = 5.4 Hz, 1H), 4.98 (d, J = 10.9 Hz, 1H), (m, 4H), (m, 6H), 4.51 (d, J = 11.0 Hz, 1H), 4.41 (d, J = 12.1 Hz, 1H), 4.09 (ddd, J = 9.8, 3.6, 2.0 Hz, 1H), (m, 3H), 3.76 (dd, J = 10.6, 3.6 Hz, 1H), (m, 7H), 3.00 (dd, J = 13.5, 2.9 Hz, 1H), (m, 1H), 2.30 (ddd, J = 13.5, 4.9, 1.3 Hz, 1H), 2.04 (ddd, J = 13.4, 11.5, 5.7 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 138.9, 138.7, 138.6, (2), 138.2, 98.1, 82.1, 81.0, 80.4, 80.2, 78.5, 78.1, 75.8, 75.3, 75.0, 73.6, 73.5, 72.0, 71.4, 69.8, 68.9, 55.4, 36.0, 32.2; HRMS (ESI) m/z calcd for C55H60O9SNa [M + Na] , found Methyl 2,3,6-tri-O-benzyl-4-S-[2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl]-4-thio-α-Dgalactopyranoside (56). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-Dglucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), methyl 2,3,6-tri-O-benzyl-4-S-(pyrrolidine-2,5- dione)-4-thio-α-d-galactopyranoside S25 (47.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 56 (48.2 mg, 48%) as a colorless oil: = +9.1 (c = 0.90, CHCl3); IR (ATR) ν = 3028, 2862, 1495, 1452, 1355, 1207, 1088, 1027, 908, 843, 732, 695, 606, 462 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 33H), (m, 2H), 4.95 (d, J = 10.7 Hz, 1H), (m, 5H), (m, 2H), (m, 8H), 4.25 (ddd, J = 6.3, 4.4, 1.7 Hz, 1H), 4.07 (qd, J = 9.7, 3.5 Hz, 2H), (m, 2H), (m, 5H), 3.39 (d, J = 5.0 Hz, 4H), 3.29 (ddt, J = 9.6, 4.7, 2.9 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 138.9, 138.7, 138.7, 138.6, 138.3, 138.3, 128.5, 128.5, 128.5, 128.4, 128.3, 128.2, 128.1, (2), 127.9, (2), (2), 127.6, 127.5, 99.0, 86.4, 84.6, 82.8, 78.9 (2), 78.0, 75.8, 75.0, 74.9, 74.0, 73.5, 73.0, 72.2, 70.0, 69.4, 55.3, 47.9; HRMS (ESI) m/z calcd for C62H66O10SNa [M + Na] , found S20

21 Methyl 2,3,6-tri-O-benzyl-4-S-[2,3,4,6-tetra-O-benzyl-α-D-mannopyranosyl]-4-thio-α-Dgalactopyranoside (57). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-α-Dmannopyranosyl)tri-n-butylstannane S15 (122 mg, mmol), methyl 2,3,6-tri-O-benzyl-4-S-(pyrrolidine- 2,5-dione)-4-thio-α-D-galactopyranoside S25 (47.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 57 (54.2 mg, 54%) as a colorless oil: = +5.7 (c =10.4, CHCl3); IR (ATR) ν = 3033, 2865, 1499, 1458, 1357, 1096, 1044, 910, 735, 689 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 33H), (m, 2H), 5.51 (d, J = 1.7 Hz, 1H), (m, 3H), (m, 10H), 4.46 (d, J = 10.7 Hz, 1H), 4.30 (d, J = 12.0 Hz, 1H), (m, 3H), (m, 2H), 3.89 (dd, J = 9.0, 3.0 Hz, 1H), 3.77 (dd, J = 9.8, 7.3 Hz, 1H), (m, 4H), 3.34 (s, 3H), 3.27 (dd, J = 11.1, 1.6 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 138.8, 138.6, 138.5, 138.4, 138.2, 137.8, 128.7, (2), (2), 128.3, 128.2, (2), 128.0, 127.9, 127.8, 127.7, 127.6, 127.5, 127.3, 127.1, 99.0, 83.9, 80.7, 77.7, 76.6, 76.1, 75.2, 74.7, 74.0, 73.8, 73.5, 72.6, 72.2, 71.9, 71.7, 69.8, 68.5, 68.2, 55.5, 50.6; HRMS (ESI) m/z calcd for C62H66O10SNa [M + Na] , found Methyl 2,3,6-tri-O-benzyl-4-S-[2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl]-6-thio-α-Dglucopyranoside (58). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)trin-butylstannane 2 (122 mg, mmol), methyl 2,3,6-tri-O-benzyl-4-S-(pyrrolidine-2,5-dione)-4-thio-α-Dglucopyranoside S26 (47.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 58 (56.2 mg, 56%) as a colorless oil: = +2.3 (c = 21.8, CHCl3); IR (ATR) ν = 3033, 2899, 2866, 1499, 1458, 1361, 1048, 914, 735, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 35H), (m, 8H), (m, 2H), (m, 4H), 4.44 (d, J = 1.8 Hz, 2H), 4.12 (dd, J = 10.7, 3.4 Hz, 1H), 4.02 (ddd, J = 11.1, 3.4, 1.8 Hz, 1H), 3.92 (dd, J = 10.6, 9.1 Hz, 1H), 3.71 (dd, J = 10.7, 1.8 Hz, 1H), (m, 5H), (m, 5H), 3.23 (t, J = 10.8 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 139.0, (2), (3), 138.2, (2), (2), 128.3, (2), 128.0, (3), 127.8, (2), (2), 127.5, 127.3, 98.5, 87.0, 84.1, 81.9, 81.1, 79.0, 77.9, 77.6, 75.9, 75.4, 75.0, 73.7, 73.5, 71.1, 69.5, 69.2, 55.3, 47.7; HRMS (ESI) m/z calcd for C62H66O10SNa [M + Na] , found S21

22 Methyl 2,3,6-tri-O-benzyl-4-S-[2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl]-6-thio-α-Dglucopyranoside (59). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-α-Dgalactopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), methyl 2,3,6-tri-O-benzyl-4-S-(pyrrolidine- 2,5-dione)-4-thio-α-D-glucopyranoside S26 (47.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 59 (61.2 mg, 61%) as a colorless oil: = +4.3 (c = 19.0, CHCl3); IR (ATR) ν = 3033, 2888, 2866, 1468, 1458, 1400, 1048, 915, 732, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 35H), (m, 2H), (m, 4H), (m, 6H), (m, 2H), 4.33 (q, J = 11.8 Hz, 2H), 4.07 (dd, J = 10.6, 3.7 Hz, 1H), (m, 5H), (m, 5H), 3.32 (s, 3H), 3.17 (t, J = 10.9 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 139.1, 138.9, (2), (2), 138.1, (2), 128.3, (3), 128.1, 128.0, (2), (2), 127.7, (2), (2), 127.3, 98.5, 85.2, 84.4, 81.2, 78.6, 77.9, 77.0, 76.0, 75.6, 74.7, 73.8, 73.6, 73.5, 73.2, 72.8, 71.4, 69.6, 68.8, 55.3, 48.0; HRMS (ESI) m/z calcd for C62H66O10SNa [M + Na] , found Methyl 2,3,6-tri-benzyl-O-4-S-[2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl]-6-thio-α-Dglucopyranoside (60). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)trin-butylstannane 2 (122 mg, mmol), methyl 2,3,6-tri-O-benzyl-4-S-(pyrrolidine-2,5-dione)-4-thio-α-Dglucopyranoside S26 (47.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 60 (55.2 mg, 55%) as a colorless oil: = +8.8 (c = 20.0, CHCl3); IR (ATR) ν = 3033, 2903, 2866, 1499, 1458, 1078, 1048, 914, 735, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ 7.38 (d, J = 4.4 Hz, 1H), 7.29 (ddt, J = 5.7, 4.4, 1.9 Hz, 26H), (m, 4H), 7.09 (ddt, J = 17.5, 7.6, 2.4 Hz, 4H), 6.02 (d, J = 5.0 Hz, 1H), 5.19 (d, J = 12.1 Hz, 1H), (m, 2H), (m, 4H), (m, 6H), 4.30 (d, J = 12.1 Hz, 1H), 4.18 (d, J = 11.9 Hz, 1H), (m, 2H), (m, 8H), 3.42 (s, 4H), 3.08 (td, J = 10.5, 5.1 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 139.2, 138.9, 138.5, 138.1, 138.0, 137.8, 128.7, (2), (3), 128.3, 128.2, 128.1(2), (2), 127.8, 127.7, (3), (2), 126.4, 98.3, 84.6, 82.5, 82.3, 81.2, 79.2, 77.3, 75.6, 75.4, 75.2, 73.7, 73.6, 73.2, 71.6, 71.5, 70.4, 68.4, 65.5, 55.5, 44.5; HRMS (ESI) m/z calcd for C62H66O10SNa [M + Na] , found S22

23 2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl-2,3,4,6-tetra-O-acetyl-1-thio-β-glucopyranoside (61). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 2,3,4,6-tetra-O-acetyl-1-S-(pyrrolidine-2,5-dione)-1-thio-β-D-glucopyranoside S27 (46.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 2:1) 61 ( 37.2 mg, 42%) as a colorless foam: = -1.3 (c = 6.05, CHCl3); IR (ATR) ν = 2929, 2865, 1752, 1458, 1368, 1216, 1037, 914, 739, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 18H), (m, 2H), (m, 3H), (m, 7H), (m, 3H), 4.13 (dd, J = 12.4, 4.6 Hz, 1H), 4.04 (dd, J = 12.3, 2.4 Hz, 1H), (m, 2H), (m, 2H), (m, 3H), 2.05 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 2.01 (s, 3H); 13 C NMR (75 MHz, CDCl3) δ 170.8, 170.4, 169.6, 169.5, 138.5, 138.2, 138.1, 137.8, (2), (2), (2), (2), (3), 86.8, 81.8, 81.7, 80.8, 79.4, 78.0, 75.9, 75.6, 75.2, 74.3, 73.5, 70.5, 69.0, 68.4, 62.1, 20.9, 20.9, 20.8, 20.7; HRMS (ESI) m/z calcd for C48H54O14SNa [M + Na] , found ,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl-2,3,4,6-tetra-O-benzoyl-1-thio-β-galactopyranoside (62). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 2,3,4,6-tetra-O-benzoyl-S-(pyrrolidine-2,5-dione)-1-thio-β-D-glucopyranoside S28 (46.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 2:1) 62 ( 45.2 mg, 51%) as a colorless oil: = (c = 0.50, CHCl3); IR (ATR) ν = 3063, 2866, 1727, 1601, 1494, 1451, 1351, 1263, 1091, 907, 707, 594 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 7H), (m, 2H), (m, 1H), (m, 26H), (m, 4H), (m, 2H), 5.59 (dd, J = 9.9, 3.5 Hz, 1H), 5.28 (d, J = 10.1 Hz, 1H), (m, 5H), 4.67 (d, J = 10.6 Hz, 1H), (m, 4H), (m, 1H), (m, 1H), (m, 5H), (m, 1H); 13 C NMR (75 MHz, CDCl3) δ 166.0, 165.7, (2), 138.5, 138.3, 137.9, 133.7, (2), 130.2, 130.1, 129.9, 129.6, 129.4, 129.2, 129.0, (2), 128.7, 128.6, (3), (3), 128.1, 128.0, (2), 127.8, 86.8, 81.7, 81.3, 81.0, 79.4, 78.1, 75.9, 75.4, 75.2, 74.9, 73.6, 72.9, 69.1, 68.9, 68.7, 62.6; HRMS (ESI) m/z calcd for C68H62O14SNa [M + Na] , found S23

24 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl-2,3,4,6-tetra-O-acetyl-1-thio-β-glucopyranoside (63). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)tri-n-butylstannane 2 (122 mg, mmol), 2,3,4,6-tetra-O-acetyl-1-S-(pyrrolidine-2,5-dione)-1-thio-β-D-glucopyranoside S27 (46.1 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 2:1) 63 ( 45.2 mg, 51%) as a colorless oil: = (c = 8.40, CHCl3); IR (ATR) ν = 2921, 2869, 1752, 1458, 1368, 1219, 1033, 914, 739, 702 cm - 1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 18H), (m, 2H), 5.77 (d, J = 4.8 Hz, 1H), (m, 3H), 4.91 (d, J = 10.9 Hz, 1H), (m, 6H), (m, 2H), (m, 2H), 4.02 (dd, J = 12.4, 2.2 Hz, 1H), (m, 6H), 2.03 (s, 3H), 2.02 (s, 3H), 2.01 (s, 3H), 2.00 (s, 3H); 13 C NMR (75 MHz, CDCl3) δ 170.7, 170.4, 169.4, 169.3, 138.7, 138.3, 138.0, 137.7, 128.6, (2), 128.2, (2), 128.0, (2), (2), 83.5, 82.6, 82.4, 79.2, 76.2, 75.8, 75.3, 74.3, 73.7, 72.0, 71.9, 71.3, 68.4, 68.0, 62.0, 20.9, 20.8 (2), 20.7; HRMS (ESI) m/z calcd for C48H54O14SNa [M + Na] , found Ethyl N-(tert-butoxycarbonyl)-S-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-L-cysteinate (64). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 (81.4 mg, mmol), (R)-ethyl 2-((tert-butoxycarbonyl)amino)-3-((2,5-dioxopyrrolidin-1-yl)thio)propanoate S29 (51.9 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 90 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 64 ( 40.1 mg, 52%) as a colorless foam: = -3.3 (c = 1.00, CHCl3); IR (ATR) ν = 3361, 3030, 2977, 2903, 1713, 1496, 1453, 1365, 1159, 1062, 735, 697 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 18H), (m, 2H), 5.86 (d, J = 8.0 Hz, 1H), (m, 3H), (m, 2H), (m, 3H), 4.46 (d, J = 9.7 Hz, 1H), 4.19 (qd, J = 7.1, 1.2 Hz, 2H), (m, 4H), (m, 2H), 3.24 (dd, J = 14.2, 4.3 Hz, 1H), 3.12 (dd, J = 14.3, 5.9 Hz, 1H), 1.45 (s, 9H), 1.25 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl3) δ 170.8, 155.5, 138.6, 138.2, 138.1, 137.9, (3), 128.4, (2), (2), (2), 86.7, 84.9, 81.4, 80.0, 79.2, 77.8, 75.8, 75.6, 75.2, 73.7, 69.0, 61.7, 54.1, 32.7, 28.5, 14.3; HRMS (ESI) m/z calcd for C44H53O9SNNa [M + Na] , found S24

25 Ethyl N-(tert-butoxycarbonyl)-S-(2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)-L-cysteinate (65). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)tri-n-butylstannane 2 (81.4 mg, mmol), (R)-ethyl 2-((tert-butoxycarbonyl)amino)-3-((2,5-dioxopyrrolidin-1-yl)thio)propanoate S29 (51.9 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 90 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 65 (35.5 mg, 46%) as a colorless foam: = +5.8 (c = 8.00, CHCl3); IR (ATR) ν = 3342, 2925, 2869, 1718, 1499, 1458, 1163, 1074, 1029, 739, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 18H), (m, 2H), 5.77 (d, J = 8.8 Hz, 1H), 5.32 (d, J = 4.9 Hz, 1H), 4.93 (d, J = 10.8 Hz, 1H), (m, 2H), (m, 4H), (m, 2H), 4.19 (q, J = 7.2 Hz, 2H), 4.12 (dt, J = 9.5, 2.1 Hz, 1H), (m, 5H), 3.23 (dd, J = 14.2, 5.6 Hz, 1H), 2.86 (dd, J = 14.2, 4.2 Hz, 1H), 1.45 (s, 9H), 1.27 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl3) δ 171.1, 155.6, 138.8, 138.3, 138.0, 137.8, 128.6, 128.5, 128.5, 128.2, 128.1, 128.1, 128.1, 128.0, 127.9, 127.8, 127.8, 85.4, 82.4, 80.1, 79.6, 78.1, 75.9, 75.3, 73.7, 72.6, 71.5, 68.6, 61.7, 53.9, 34.0, 28.5, 14.3; HRMS (ESI) m/z calcd for C44H53O9SNNa [M + Na] , found Ethyl N-(tert-butoxycarbonyl)-S-(2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(14)-2,3,6-tri-Obenzyl-β-D-glucopyranosyl)-L-cysteinate (66). According to the general protocol B, [2,3,4,6-tetra-Obenzyl-β-D-galactopyranosyl-(1 4)-2,3,6-tri-O-benzyl-β-D-glucopyranosyl]tri-n-butylstannane 2 (125 mg, mmol), (R)-ethyl 2-((tert-butoxycarbonyl)amino)-3-((2,5-dioxopyrrolidin-1-yl)thio)propanoate S29 (51.9 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 90 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 5:1) 66 ( 43.3 mg, 36%) as a colorless foam: = (c = 12.8, CHCl3); IR (ATR) ν = 3361, 3033, 2865, 1715, 1499, 1458, 1368, 1163, 1063, 914, 735, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 35H), 5.86 (d, J = 8.0 Hz, 1H), 5.11 (d, J = 10.7 Hz, 1H), 4.98 (d, J = 11.5 Hz, 1H), (m, 7H), (m, 3H), (m, 3H), (m, 4H), 4.01 (t, J = 9.4 Hz, 1H), 3.93 (d, J = 2.9 Hz, 1H), 3.86 (dd, J = 10.9, 3.8 Hz, 1H), (m, 2H), 3.58 (t, J = 8.8 Hz, 1H), (m, 6H), (m, 1H), (m, 1H), 1.40 (s, 9H), 1.24 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl3) δ 170.8, 155.5, (2), 138.9, 138.7, 138.4, 138.2, (3), (2), (2), 128.2, 128.1, 128.0, (2), (2), 127.7, (2), (2), 127.2, 102.9, 84.9, 84.7, 82.6, 80.6, 80.1, 79.5, 76.4, 75.6, 75.5, 75.4, 74.8, 73.8, 73.5, 73.3, 73.1, 72.7, 68.3, 68.0, 61.6, 54.1, 32.4, 28.4, 14.3; HRMS (ESI) m/z calcd for C71H81O14SNNa [M + Na] , found S25

26 tert-butyl N-((tert-butoxycarbonyl)-L-phenylalanyl)-S-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-Lcysteinate (67). According to the general protocol B, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-nbutylstannane 2 (81.4 mg, mmol), (R)-tert-butyl 2-((S)-2-((tert-butoxycarbonyl)amino)-3- phenylpropanamido)-3-((2,5-dioxopyrrolidin-1-yl)thio)propanoate S30 (78.2 mg, mmol), JackiePhos (44.0 mg, mmol), and CuCl (5.00 mg, mmol) were added to anhydrous 1,4-dioxane (3.00 ml). The reaction mixture was heated under N2 at 90 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 3:1) 67 (56.8 mg, 60%) as a colorless foam: = +5.9 (c = 14.3, CHCl3); IR (ATR) ν = 3301, 2981, 2938, 1663, 1499, 1468, 1372, 1253, 1156, 1056, 914, 847, 735, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 20H), 5.55 (s, 1H), (m, 10H), (m, 3H), (m, 1H), (m, 6H), 2.80 (dd, J = 13.9, 8.2 Hz, 1H), 1.37 (s, 9H), 1.35 (s, 9H); 13 C NMR (75 MHz, CDCl3) δ 172.0, 169.0, 155.8, 138.7, 138.3, 138.1, 137.9, 137.1, 136.7, 129.6, 129.4, 128.8, (2), 128.5, 128.4, 128.2, 128.1, (2), 127.7, 126.8, 86.4, 83.1, 82.7, 82.0, 80.1, 78.9, 78.0, 75.8, 75.7, 74.9, 73.5, 68.9, 55.5, 52.8, 38.6, 28.4, 28.1; HRMS (ESI) m/z calcd for C55H66O10SN2Na [M + Na] , found ((4-Methoxyphenyl)thio)tetrahydro-2H-pyran (71). According to the general protocol A, tri-nbutyl(tetrahydro-2h-pyran-2-yl)stannane 2 (75.0 mg, mmol), 1-((4-methoxyphenyl)thio)pyrrolidine- 2,5-dione S14 (23.7 mg, mmol), CuCl (1.00 mg, mmol), and KF (17.4 mg, mmol) in PhMe (2.00 ml) were heated under N2 at 130 ºC for 96 h afforded after chromatographic purification on SiO2 (Hexanes/EtOAc, 99:1) 71 (12.5 mg, 56%) as a colorless oil: 1 H NMR (300 MHz, CDCl3) δ 7.44 (d, J = 8.8 Hz, 2H), 6.84 (d, J = 8.8 Hz, 2H), 5.01 (dd, J = 6.2, 3.7 Hz, 1H), (m, 1H), 3.79 (s, 3H), (m, 1H), (m, 8H). Characterization data matched the literature report. 7 2-((3,4-Dimethoxyphenyl)thio)tetrahydro-2H-pyran (72). According to the general protocol A, tri-nbutyl(tetrahydro-2h-pyran-2-yl)stannane 2 (75.0 mg, mmol), 1-((3,4-dimethoxyphenyl)thio)pyrrolidine- 2,5-dione S8 (26.7 mg, mmol), CuCl (1.00 mg, mmol), and KF (17.4 mg, mmol) in PhMe (2.00 ml) were heated under N2 at 130 ºC for 96 h afforded after chromatographic purification on SiO2 (Hexanes/EtOAc, 19:1) 72 (13.6 mg, 54%) as a colorless oil: 1 H NMR (300 MHz, CDCl3) δ (m, 2H), 6.80 (d, J = 6.8 Hz, 1H), (m, 1H), (m, 1H), 3.87 (s, 3H), 3.86 (s, 3H), S26

27 (m, 1H), (m, 1H), (m, 2H), (m, 3H); 13 C NMR (75 MHz, CDCl3) δ (2), 125.7, 125.4, 116.0, 111.4, 86.3, 64.9, 55.9 (2), 31.5, 25.5, 21.8; HRMS (ESI) calcd for C13H18O3SNa [M + Na] + : , found ((4-Methoxyphenyl)thio)tetrahydrofuran (73). According to the general protocol A, tri-nbutyl(tetrahydrofuran-2-yl)stannane 2 (72.2 mg, mmol), 1-((4-methoxyphenyl)thio)pyrrolidine-2,5- dione S14 (23.7 mg, mmol), CuCl (1.00 mg, mmol), and KF (17.4 mg, mmol) in PhMe (2.00 ml) were heated under N2 at 130 ºC for 96 h afforded after chromatographic purification on SiO2 (Hexanes/EtOAc, 99:1) 73 (14.9 mg, 71%) as a colorless oil: 1 H NMR (300 MHz, CDCl3) δ 7.46 (d, J = 8.8 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 5.47 (dd, J = 7.0, 3.6 Hz, 1H), (m, 2H), 3.79 (s, 3H), (m, 1H), (m, 3H).Characterization data matched the literature report. 3 2-((3,4-Dimethoxyphenyl)thio)tetrahydrofuran (74). According to the general protocol A, tri-nbutyl(tetrahydrofuran-2-yl)stannane 2 (72.2 mg, mmol), 1-((3,4-dimethoxyphenyl)thio)pyrrolidine-2,5- dione S8 (26.7 mg, mmol), CuCl (1.00 mg, mmol), and KF (17.4 mg, mmol) in PhMe (2.0 ml) were heated under N2 at 130 ºC for 96 h afforded after chromatographic purification on SiO2 (Hexanes/EtOAc, 19:1) 74 (15.1 mg, 63%) as a colorless oil: 1 H NMR (300 MHz, CDCl3) δ (m, 2H), 6.81 (d, J = 8.2 Hz, 1H), 5.51 (dd, J = 7.2, 3.9 Hz, 1H), (m, 1H), (m, 1H), 3.88 (s, 3H), 3.86 (s, 3H), (m, 1H), (m, 3H); 13 C NMR (75 MHz, CDCl3) δ (2), 126.0, 125.6, 116.1, 111.5, 88.2, 67.3, 55.9 (2), 32.5, 24.9; HRMS (ESI) calcd for C12H16O3SNa [M + Na] + : , found tert-butyl 2-((4-methoxyphenyl)thio)pyrrolidine-1-carboxylate (75). According to the general protocol A, tert-butyl 2-(tri-n-butylstannyl)pyrrolidine-1-carboxylate 8 (46.0 mg, mmol), 1,2-bis(4- methoxyphenyl)disulfane S4 (41.8 mg, mmol), CuCl (1.00 mg, mmol), and KF (17.4 mg, mmol) in PhMe (2.0 ml) were heated under N2 at 130 ºC for 96 h afforded after chromatographic purification on SiO2 (Hexanes/EtOAc, 19:1) 75 (19.7 mg, 64%) as a colorless oil: 1 H NMR (300 MHz, CDCl3) δ 7.42 (d, J = 9.4 Hz, 2H), (m, 2H), (m, 1H), 3.80 (s, 3H), 3.39 (s, 2H), (m, 4H), (m, 9H). Characterization data matched the literature report. 9 S27

28 Benzyl-4-((4-methoxyphenyl)thio)azetidin-2-one (76). According to the general protocol A, 1-benzyl-4-(trin-butylstannyl)azetidin-2-one S31 (45.0 mg, mmol), 1,2-bis(4-methoxyphenyl)disulfane S4 (55.7 mg, mmol), CuI (1.90 mg, mmol) and LiF (7.80 mg, mmol) in 1,4-dioxane (2.0 ml) were heated under N2 at 130 ºC for 96 h afforded after chromatographic purification on SiO2 (Hexanes/EtOAc 9:1) 76 (20.7 mg, 69%) as a colorless oil: 1 H NMR (300 MHz, CDCl3) δ (m, 5H), (m, 2H), (m, 2H), 4.73 (d, J = 15.1 Hz, 1H), 4.65 (dd, J = 4.9, 2.2 Hz, 1H), 4.12 (d, J = 15.1 Hz, 1H), 3.81 (s, 3H), 3.20 (ddd, J = 14.9, 4.9, 0.6 Hz, 1H), 2.78 (ddd, J = 14.9, 2.2, 1.0 Hz, 1H); 13 C NMR (75 MHz, CDCl3) δ 165.3, 160.6, 137.0, 135.5, 128.8, 128.5, 127.8, 119.7, 114.9, 58.3, 55.4, 44.2, 43.9; HRMS (ESI) calcd for C17H17NO2SNa [M + Na] + : , found ,2-Bis(4-fluorophenyl)disulfane (S1). 11 According to the general procedure C, NaBO3 H2O (600.0 mg, 6.00 mmol) was added to a stirring solution of 4-fluorobenzenethiol (320 μl, 3.00 mmol) in AcOH (7.50 ml) and H2O (3.00 ml). The reaction mixture was stirred for 4 h and concentrated in vacuo. The crude mixture was purified via flash chromatography on SiO2 (Hexanes) to afford S1 (299 mg, 78%) as a pale yellow oil: 1 H NMR (300 MHz, CDCl3) δ (m, 4H), (m, 4H); 13 C NMR (75 MHz, CDCl3) δ 164.4, 161.1, (2), 131.4, 131.3, 116.5, 116.2; 19 F NMR (282 MHz, CDCl3) δ (tt, J = 8.5, 5.1 Hz). Characterization data matched the literature report. 11 1,2-Bis(4-(tert-butyl)phenyl)disulfane (S2). 11 According to the general procedure C, NaBO3 H2O (9.60 g, 96.0 mmol) was added to a stirring solution of 4-(tert-butyl)benzenethiol (4.00 g, 24.0 mmol) in AcOH (15.0 ml) and H2O (10.0 ml). The reaction mixture was stirred for 4 h and concentrated in vacuo. The crude mixture was purified via flash chromatography on SiO2 (Hexanes) to afford S2 (3.20 g, 80%) as a white solid: 1 H NMR (300 MHz, CDCl3) δ 7.52 (dd, J = 8.6, 2.0 Hz, 4H), 7.39 (dd, J = 8.5, 1.7 Hz, 4H), 1.37 (s, 9H), 1.36 (s, 9H); 13 C NMR (75 MHz, CDCl3) δ 149.7, 149.3, 128.8, 124.0, 114.2, 111.5, 56.1, Characterization data matched the literature report. 11 S28

29 N,N'-(Disulfanediylbis(4,1-phenylene))diacetamide (S3). 12 According to the general procedure C, NaBO3 H2O (600 mg, 6.00 mmol) was added to a stirring solution of 4-acetamidobenzenethiol (1.00 g, 6.00 mmol) in AcOH (10.0 ml) and H2O (4.00 ml). The reaction mixture was stirred for 4 h and concentrated in vacuo. The crude mixture was purified via flash chromatography on SiO2 (Hexanes) to afford S3 (8.17 g, 82%) as a light yellow solid: 1 H NMR (300 MHz, (CD3)2SO) δ (s, 2H), (m, 4H), (m, 4H), 2.04 (s, 6H); 13 C NMR (75 MHz, (CD3)2SO) δ 168.5, 139.5, 130.1, 129.3, 119.7, Characterization data matched the literature report. 12 1,2-Bis(4-methoxyphenyl)disulfane (S4). 12 According to the general procedure C, NaBO3 H2O (600 mg, 6.00 mmol) was added to a stirring solution of 4-methoxybenzenethiol (370 μl, 3.00 mmol) in AcOH (7.50 ml) and H2O (3.00 ml). The reaction mixture was stirred for 4 h and concentrated in vacuo. The crude mixture was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 50:1) to afford S4 (430 mg, 99%) as a pale yellow solid: 1 H NMR (300 MHz, CDCl3) δ (m, 4H), (m, 4H), 3.80 (s, 6H); 13 C NMR (75 MHz, CDCl3) δ 160.0, 132.7, 128.5, 114.7, Characterization data matched the literature report. 12 1,2-Bis(4-(trifluoromethoxy)phenyl)disulfane (S5). 13 According to the general procedure C, NaBO3 H2O (300 mg, 3.00 mmol) was added to a stirring solution of 4-(trifluoromethoxy)benzenethiol (291 mg, 1.50 mmol) in AcOH (5.00 ml) and H2O (2.00 ml). The reaction mixture was stirred for 4 h and concentrated in vacuo. The crude mixture was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 100:1) to afford S5 (250 mg, 86%) as a pale yellow oil: 1 H NMR (300 MHz, CDCl3) δ (m, 4H), (m, 4H); 13 C NMR (75 MHz, CDCl3) δ 148.8, 135.3, 129.4, 122.2, 121.8, 118.8; 19 F NMR (282 MHz, CDCl3) δ Characterization data matched the literature report ((3-Methoxyphenyl)thio)pyrrolidine-2,5-dione (S6). 14 According to the general procedure D, to a flamedried round bottom flask was charged N-chlorosuccinimide (140 mg, 1.05 mmol) and anhydrous CH2Cl2 (4.00 ml) under N2. The mixture was cooled to 0 C and 3-methoxybenzenethiol (140 mg, 1.00 mmol) in CH2Cl2 (1.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 S29

30 minutes followed by the addition of triethylamine (154 μl, 1.10 mmol) in CH2Cl2 (1.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2 and the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 4:1) to afford S6 (105 mg, 44%) as a white solid: 1 H NMR (300 MHz, CDCl3) δ (m, 1H), (m, 2H), 6.88 (ddd, J = 8.2, 2.6, 1.2 Hz, 1H), 3.79 (s, 3H), 2.83 (s, 4H); 13 C NMR (75 MHz, CDCl3) δ 176.4, 160.1, 135.1, 130.3, 124.1, 116.9, 116.1, 55.6, Characterization data matched the literature report. 14 1,2-Bis(3,5-dimethylphenyl)disulfane (S7). 15 According to the general procedure C, NaBO3 H2O (300 mg, 3.00 mmol) was added to a stirring solution of 3,5-dimethylbenzenethiol (207 mg, 1.50 mmol) in AcOH (5.00 ml) and H2O (2.00 ml). The reaction mixture was stirred for 4 h and concentrated in vacuo. The crude mixture was purified via flash chromatography on SiO2 (Hexanes) to afford S7 (150 mg, 73%) as a pale yellow oil: 1 H NMR (300 MHz, CDCl3) δ 7.13 (s, 4H), 6.86 (s, 2H), 2.29 (s, 12H); 13 C NMR (75 MHz, CDCl3) δ 138.9, 137.0, 129.1, 125.3, Characterization data matched the literature report ((3,4-Dimethoxyphenyl)thio)pyrrolidine-2,5-dione (S8). According to the general procedure D, to a flame-dried round bottom flask was charged N-chlorosuccinimide (140 mg, 1.05 mmol) and anhydrous CH2Cl2 (4.00 ml) under N2. The mixture was cooled to 0 C and 3,4-dimethoxybenzenethiol (170 mg, 1.00 mmol) in CH2Cl2 (1.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (154 μl, 1.10 mmol) in CH2Cl2 (1.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2 and the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 1:1) to afford S8 (219 mg, 82%) as a white solid: IR (ATR) ν = 3011, 2936, 2843, 1722, 1584, 1506, 1298, 1234, 1138, 1022, 754 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ 7.43 (dd, J = 8.3, 2.1 Hz, 1H), 7.33 (d, J = 2.1 Hz, 1H), 6.81 (d, J = 8.3 Hz, 1H), 3.88 (s, 3H), 3.88 (s, 3H), 2.77 (s, 4H); 13 C NMR (75 MHz, CDCl3) δ 176.7, 151.6, 149.1, 129.4, 124.7, 118.2, 111.3, 56.3, 56.1, 28.7; HRMS (ESI) m/z calcd for C12H13NO4SNa [M + Na] , found ,2-Di(naphthalen-2-yl)disulfane (S9). 16 A modified procedure to the general procedure C, iodine (190 mg, 0.75 mmol) was added to a stirring solution of naphthalene-2-thiol (240 mg, 1.50 mmol) in MeOH (7.50 ml). The reaction mixture was stirred for 4 h and quenched with sat. Na2S2O3. The resulting solution was extracted S30

31 with CH2Cl2. The organic solution was dried with Na2SO4, filtered, and concentrated. The crude mixture was purified via flash chromatography on SiO2 (Hexanes) to afford S9 (200 mg, 84%) as a white solid: 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 4H), (m, 2H), 7.62 (dd, J = 8.7, 1.9 Hz, 2H), (m, 4H); 13 C NMR (75 MHz, CDCl3) δ 134.4, 133.6, 132.7, 129.1, 127.9, 127.6, 126.9, 126.7, 126.4, Characterization data matched the literature report (iso-Propylthio)isoindoline-1,3-dione (S10). To a flame-dried round bottom flask was charged 2- propanethiol (186 μl, 2.00 mmol) and triethylamine (13.6 μl, 0.10 mmol) in CH2Cl2 (4.00 ml) at 0 C under N2. SO2Cl2 (162 μl, 2.00 mmol) was added dropwise and the reaction was allowed to stir for 30 minutes. A solution of phthalimide (294 mg, 2.00 mmol) and triethylamine (351 μl, 2.50 mmol) in CH2Cl2 (2.00 ml) was added dropwise. The reaction was allowed to stir for an additional 1.5 h while warming up to room temperature. When the reaction is completed, the crude reaction mixture was washed with brine and water. The organic layer was collected, dried (Na2SO4), filtered, and concentrated. The crude solid was triturated with a 1:1 mixture of hexanes and ethyl acetate to afford S10 (320 mg, 73%) as a white solid: IR (ATR) ν = 3003, 2947, 2255, 1745, 1380, 1290, 1048, 724 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 2H), 3.46 (hept, J = 6.7 Hz, 1H), 1.26 (d, J = 6.7 Hz, 6H); 13 C NMR (75 MHz, CDCl3) δ 168.9, 134.7, 132.1, 124.0, 41.5, 21.1; HRMS (ESI) m/z calcd for C11H11NO2SNa [M + Na] , found tert-butyl-(2-((2,5-dioxopyrrolidin-1-yl)thio)ethyl)carbamate (S11). According to the general procedure D, to a flame-dried round bottom flask was charged N-chlorosuccinimide (140 mg, 1.05 mmol) and anhydrous CH2Cl2 (4.00 ml) under N2. The mixture was cooled to 0 C and 2-(Boc-amino)ethanethiol (169 μl, 1.00 mmol) in CH2Cl2 (1.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (154 μl, 1.10 mmol) in CH2Cl2 (1.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2 and the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 3:2) to afford S11 (185 mg, 68%) as a white solid: IR (ATR) ν = 3387, 2977, 2933, 1711, 1510, 1309, 1249, 1145, 758 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ 5.45 (s, 1H), 3.23 (td, J = 6.5, 5.2 Hz, 2H), (m, 2H), 2.85 (s, 4H), 1.44 (s, 9H); 13 C NMR (75 MHz, CDCl3) δ 177.6, 155.9, 79.7, 38.9, 38.5, 28.8, 28.5; HRMS (ESI) m/z calcd for C11H18N2O4SNa [M + Na] , found S31

32 2-Ethylhexyl-3-((2,5-dioxopyrrolidin-1-yl)thio)propanoate (S12). According to the general procedure D, to a flame-dried round bottom flask was charged N-chlorosuccinimide (280 mg, 2.10 mmol) and anhydrous CH2Cl2 (8.00 ml) under N2. The mixture was cooled to 0 C and 2-ethylhexyl-3-mercaptopropionate (292 μl, 2.00 mmol) in CH2Cl2 (2.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (308 μl, 2.20 mmol) in CH2Cl2 (2.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 3:1) to afford S12 (450 mg, 71%) as a colorless oil: IR (ATR) ν = 2959, 2933, 2862, 1722, 1309, 1246, 1141, 653 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ 3.97 (dt, J = 5.9, 2.1 Hz, 2H), (m, 2H), 2.81 (s, 4H), (m, 2H), (m, 1H), (m, 8H), (m, 6H); 13 C NMR (75 MHz, CDCl3) δ 177.3, 171.8, 67.6, 38.8, 35.0, 32.9, 30.4, 29.0, 28.8, 23.8, 23.1, 14.2, 11.1; HRMS (ESI) m/z calcd for C15H25NO4SNa [M + Na] , found (R)-2,8-Dimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl trifluoromethanesulfonate (S13a). 17 To an oven-dried round-bottom flask was charged (+)-δ-tocopherol (1.60 g, 3.97 mmol, 1.00 equiv), CH2Cl2 (20.0 ml, M), and pyridine (480 μl, 5.96 mmol, 1.50 equiv). The reaction was cooled to 0 C and trifluoromethanesulfonic anhydride (800 μl, 4.77 mmol, 1.20 equiv) was added dropwise. The reaction was allowed to stir for 30 min. The mixture was quenched with H2O and extracted with CH2Cl2. The organic layers were combined, dried (Na2SO4), and concentrated. The crude mixture was purified by column chromatography on SiO2 (Hexanes) to yield S13a (2.03 g, 96%) as a colorless oil. Characterization data matched the literature report Ethylhexyl 3-(((R)-2,8-dimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)thio)propanoate (S13b). To an oven-dried sealed tube equipped was charged (R)-2,8-dimethyl-2-((4R,8R)-4,8,12- trimethyltridecyl)chroman-6-yl trifluoromethanesulfonate S13a (300 mg, mmol), Pd2(dba)3 (25.6 mg, mmol), and XantPhos (32.4 mg, mmol) under N2. 1,4-Dioxane (3.00 ml), 3-mercaptopropionic acid 2-ethylhexyl ester (140 μl, mmol, 1.10 equiv), and N,N-diisopropylethylamine (200 μl, 1.12 mmol, 2.00 equiv) were added and heated under N2 at 110 C for 20 h. After cooling to rt, the reaction mixture was filtered, concentrated, and directly purified by column chromatography on SiO2 (Hexanes:EtOAc, 1:0 then 99:1) to yield S13b (0.268 g, 79%) as a light yellow oil: = (c = 0.20, CHCl3); 1 H NMR (300 S32

33 MHz, CDCl3) δ 7.05 (s, 1H), 7.01 (s, 1H), (m, 2H), 3.03 (t, J = 7.4 Hz, 2H), (m, 2H), 2.58 (t, J = 7.4 Hz, 2H), 2.14 (s, 3H), (m, 2H), (m, 51H); 13 C NMR (75 MHz, CDCl3) δ 172.2, 152.1, 132.9, 131.6, 127.2, 122.7, 121.2, 76.4, 67.0, 40.2, 39.4, 38.8, 37.5, 37.4 (2), 37.3, 34.8 (2), 32.7, 31.3, 31.1, 30.4, 28.9, 28.0 (2), 24.5, 24.2, 23.8, 23.0, 22.7, 22.6, 22.2, 21.0, 19.8, 19.7, 16.0, 14.1, 11.0; HRMS (ESI) calcd for C38H66O3SNa [M + Na] , found (R)-2,8-Dimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chromane-6-thiol (S13c). To an oven-dried roundbottom flask was charged 2-ethylhexyl 3-(((R)-2,8-dimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6- yl)thio)propanoate S13b (257 mg, mmol) and absolute EtOH (8.60 ml, M). Sodium tert-butoxide (738 mg, 7.67 mmol) was added in one portion and stirred at rt for 0.5 h. The reaction mixture was quenched with sat. NH4Cl (aq) and extracted with CH2Cl2. The combined organic layers were dried (Na2SO4) and purified by column chromatography on SiO2 (Hexanes) to yield S13c (82.8 mg, 46%) as a colorless oil: = (c = 0.025, CHCl3); 1 H NMR (300 MHz, CDCl3) δ 6.95 (s, 1H), 6.92 (s, 1H), 3.27 (s, 1H), 2.70 (t, J = 6.8 Hz, 2H), 2.12 (s, 3H), (m, 2H), (m, 24H), (m, 12H); 13 C NMR (75 MHz, CDCl3) δ 151.2, 131.5, 129.8, 127.4, 121.4, 117.0, 76.2, 40.0, 39.4, 37.5, 37.4, 37.3, 32.8, 32.7, 31.1, 28.0, 24.8, 24.5, 24.2, 22.7, 22.6, 22.2, 20.9, 19.8, 19.7, 15.9; HRMS (ESI) calcd for C27H46OSNa [M + Na] , found (((R)-2,8-Dimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)thio)pyrrolidine-2,5-dione (S13). According to the general procedure D, to a flame-dried round bottom flask was charged N- chlorosuccinimide (100 mg, mmol) and anhydrous CH2Cl2 (0.750 ml) under N2. The mixture was cooled to 0 C and (R)-2,8-dimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chromane-6-thiol S13c (300 mg, mmol) in CH2Cl2 (0.720 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (110 μl, mmol) in CH2Cl2 (0.790 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 4:1) to afford S13 (70.7 mg, 19%) as a light yellow oil: = (c = 0.08, CHCl3); 1 H NMR (300 MHz, CDCl3) δ 7.38 (s, 2H), (m, 6H), 2.10 (s, 3H), (m, 2H), (m, 24H), (m, 12H); 13 C NMR (75 MHz, CDCl3) δ 176.7, 154.9, 135.6, 134.9, 127.5, 122, 121.2, 77.2, 40.3, 39.4, 37.4 (2), 37.3, 32.8, 32.7, 30.7, 28.6, 28.0, 24.8, 24.4, 24.3, 22.7, 22.6, 22.0, 20.9, 19.8, 19.6, 15.9; HRMS (ESI) calcd for C31H49NO3SNa [M + Na] , found S33

34 1-((4-Methoxyphenyl)thio)pyrrolidine-2,5-dione (S14). 18 According to the general procedure D, to a flamedried round bottom flask was charged N-chlorosuccinimide (701 mg, 5.25 mmol) and anhydrous CH2Cl2 (5.25 ml) under N2. The mixture was cooled to 0 C and 4-methoxybenzenethiol (610 μl, 5.00 mmol) in CH2Cl2 (5.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (770 μl, 5.50 mmol) in CH2Cl2 (5.50 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 3:1) to afford S14 (0.969 g, 82%) as a white solid: 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 2H), 3.79 (s, 3H), 2.74 (s, 4H); 13 C NMR (75 MHz, CDCl3) δ 176.6, 161.9, 137.4, 124.6, 114.8, 55.5, 28.7; Characterization data matched the literature report. 18 (2,3,4,5-Tetra-O-benzyl-α-D-mannopyranosyl)tri-n-butylstannane (S15). To a flame-dried round bottom flask was charged 1,2-O-(1-methoxyethylidene)-3,4,6-tris-O-(phenylmethyl)-β-D-mannopyranose (14.0 g, 7.92 mmol) and anh. CH2Cl2 (80.0 ml) under N2. TMSCl (11.9 mmol, 11.9 ml) was then added and the mixture was refluxed for 1 h. When the reaction is complete, the solvent was removed in vacuo. The flask containing the crude material was purged three times with N2, dissolved in anh. THF (80.0 ml), and cooled down to -40 C. Potassium tert-butoxide (2.67 g, 23.8 mmol) was added and the reaction was allowed to stir for 30 mins. The reaction was poured into a 2:1 mixture of chloroform and brine (120 ml). The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried (Na2SO4), filtered, and concentrated. The crude material was purified via recrystallization (Hexanes/EtOAc). The mostly pure epoxide was charged to a flame-dried round bottom and purged three times with nitrogen. Dry THF was added (80.0 ml) and the mixture was cooled down to -40 C. MeMgSnBu3 was then added and the reaction was stirred for 2 h. Quench the reaction with H2O and filter through a pad of Celite. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried (Na2SO4), filtered, and concentrated. A short silica column was used to obtain a mostly pure product that was used directly in the next step. 400 mg of this material was dissolved in anh. THF (2.00 ml), cooled to 0 C, and KHMDS (1.66 ml, mmol, M in PhMe) was added. The reaction mixture was stirred at 0 C for 0.5 h, BnBr (130 μl, 1.10 mmol) was added, and the reaction was allowed to warm to rt and stirred for an additional 12 h. The crude mixture was concentrated with SiO2 and purified via flash chromatography on SiO2 (Hexanes:EtOAc, 10:1) to afford S15 (415 mg, 71%) as a colorless oil: = +1.8 (c = 9.00, CHCl3); IR (ATR) ν = 3067, 3033, 2959, 2925, 2858, 1458, 1089, 739, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 18H), 4.97 (d, J = 11.2 Hz, 1H), (m, 2H), (m, 6H), 3.96 (t, J = 9.2 Hz, 1H), (m, 3H), 3.62 (dd, J = 9.1, 3.2 Hz, 1H), 3.22 (ddd, J = 9.3, 4.5, 2.8 Hz, 1H), (m, 6H), 1.26 (m, 6H), (m, 15H); 13 C NMR (75 MHz, CDCl3) δ 139.0, 138.7, 138.6, 138.5, (2), 128.4, (2), 128.0, (2), (2), 127.6, 127.5, 81.8, 80.0, 75.7, 75.1, 73.5, 72.7, 71.3, 70.1, 70.0, 29.1, 27.5, 13.8, 10.1; HRMS (ESI) m/z calcd for C46H62O5SnNa [M + Na] , found S34

35 (6-O-Acetyl-2,3,4-tri-O-benzyl-β-D-glycopyranosyl)tri-n-butylstannane (S16). To a solution of (2,3,4-tri- O-benzyl-β-D-glycopyranosyl)tri-n-butylstannane 2 (217 mg, mmol) was added acetic anhydride (1.00 ml) and pyridine (2.00 ml) at rt. The reaction was allowed to stir for 12 h. The crude mixture was concentrated with SiO2 and purified via flash chromatography on SiO2 (Hexanes:EtOAc, 10:1) to afford S16 (220 mg, 96%) as a colorless oil: = (c = 9.50, CHCl3); IR (ATR) ν = 3067, 3033, 2959, 2925, 2873, 1745, 1238, 1056, 1033, 758 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 15H), 5.05 (d, J = 11.1 Hz, 1H), (m, 3H), (m, 2H), 4.32 (dd, J = 11.7, 2.1 Hz, 1H), 4.12 (dd, J = 11.7, 5.6 Hz, 1H), (m, 2H), (m, 2H), 3.34 (ddd, J = 9.7, 5.6, 2.1 Hz, 1H), 2.03 (s, 3H), (m, 6H), (m, 6H), (m, 15H); 13 C NMR (75 MHz, CDCl3) δ 170.9, (2), 138.0, (2), 128.4, 128.1, 128.0, (2), 127.6, 127.5, 89.6, 81.8, 80.6, 79.3, 75.6, 75.3, 74.6, 74.5, 64.0, 29.2, 27.5, 20.9, 13.8, 9.2; HRMS (ESI) m/z calcd for C41H58O6SnNa [M + Na] , found (2,3,4-Tri-O-benzyl-6-O-pivaloyl-β-D-glycopyranosyl)tri-n-butylstannane (S17). To a solution of (2,3,4- tri-o-benzyl-β-d-glycopyranosyl)tri-n-butylstannane 2 (217 mg, mmol) and triethylamine (150 μl, 1.05 mmol) in anhydrous CH2Cl2 (1.50 ml) under N2 at rt was added trimethylacetyl chloride (110 μl, mmol). The reaction was allowed to stir for 12 h. The crude mixture was concentrated with SiO2 and purified via flash chromatography on SiO2 (Hexanes:EtOAc, 20:1) to afford S17 (205 mg, 85%) as a colorless oil: = (c = 3.50, CHCl3); IR (ATR) ν = 3067, 3033, 2959, 2925, 1733, 1097, 1059, 735, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 15H), 5.07 (d, J = 11.1 Hz, 1H), (m, 3H), 4.65 (d, J = 11.2 Hz, 1H), 4.60 (d, J = 10.7 Hz, 1H), 4.40 (dd, J = 11.8, 2.0 Hz, 1H), 4.11 (dd, J = 11.8, 4.4 Hz, 1H), (m, 2H), (m, 2H), 3.33 (ddd, J = 9.6, 4.4, 2.0 Hz, 1H), 1.47 (m, 6H), (m, 15H), (m, 15H); 13 C NMR (75 MHz, CDCl3) δ 178.3, 138.6, 138.5, 138.1, 128.7, 128.6, 128.4, (2), 127.9, 127.6, 127.4, 89.6, 81.9, 80.8, 79.3, 75.7, 75.4, 74.7, 74.5, 63.5, 39.0, 29.2, 27.5, 27.4, 13.8, 9.2; HRMS (ESI) m/z calcd for C44H64O6SnNa [M + Na] , found (2,3,4-Tri-O-benzyl-6-O-(4-methoxybenzyl)-β-D-glycopyranosyl)tri-n-butylstannane (S18). To a solution of (2,3,4-tri-O-benzyl-β-D-glycopyranosyl)tri-n-butylstannane 2 (217 mg, mmol) and TBAI (22.0 mg, mmol) in THF (1.50 ml) was added KHMDS (720 μl, M in PhMe) under N 2 at rt. After stirring for 1 h, PMB-Cl (81 μl, mmol) was added to the mixture and the reaction was allowed to stir for 12 h. The crude mixture was concentrated with SiO2 and purified via flash chromatography on SiO2 (Hexanes:EtOAc, 20:1) to afford S18 (130 mg, 51%) as a colorless oil: = (c = 15.5, CHCl3); IR S35

36 (ATR) ν = 3067, 3033, 2955, 2921, 2854, 1517, 1458, 1249, 1059, 698 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 17H), (m, 2H), 5.07 (d, J = 11.2 Hz, 1H), 4.96 (d, J = 10.9 Hz, 1H), (m, 2H), 4.65 (d, J = 11.0 Hz, 2H), (m, 2H), 3.81 (s, 3H), (m, 5H), 3.53 (d, J = 10.8 Hz, 1H), (m, 1H), (m, 6H), (m, 6H), (m, 15H); 13 C NMR (75 MHz, CDCl3) δ 159.2, 138.8, 138.7, 138.6, 130.9, 129.3, 128.6, 128.5, 128.4, 128.0, (2), 127.7, (2), 113.8, 89.7, 83.4, 81.8, 79.4, 69.3, 55.4, 29.2, 27.6, 13.8, 9.3; HRMS (ESI) m/z calcd for C47H64O6SnNa [M + Na] , found (3,4,6-Tri-O-benzyl-2-deoxy-α-D-galactopyranosyl)tri-n-butylstannane (S19). To a flask containing 3,4,6-tri-O-benzyl-2-deoxy-α-D-galactopyranosyl chloride (434 mg, 1.00 mmol), anh. THF (7.00 ml) was added under N2 and cooled down to -78 C. A lithium naphthalenide (2.50 ml, 2.50 mmol, 1.00 M) was added dropwise over 5 min, followed immediately by tri-n-butyltin chloride (678 μl, 2.50 mmol) in one portion. The reaction mixture was allowed to stir at -78 C for 1 h. The reaction mixture was quenched with water and extracted with EtOAc. The organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 40:1) to afford S19 (210 mg, 30%) as a colorless oil: = +3.0 (c = 7.0, CHCl3); IR (ATR) ν = 3067, 3033, 2959, 2925, 2854, 1458, 1089, 739, 698 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 15H), 4.88 (d, J = 11.8 Hz, 1H), (m, 4H), (m, 2H), 3.84 (d, J = 2.4 Hz, 1H), (m, 4H), 2.53 (td, J = 12.8, 11.9, 5.6 Hz, 1H), (m, 1H), (m, 12H), (m, 15H); 13 C NMR (75 MHz, CDCl3) δ 139.1, 138.8, 138.5, 128.6, 128.5, 128.3, 128.2, 127.8, (2), 127.6, 127.5, 77.7, 74.1, 73.8, 73.5, 70.4, 69.2, 29.3, 27.6, 13.8, 9.8; HRMS (ESI) m/z calcd for C39H56O4SnNa [M + Na] , found (2,3,4-Tri-O-benzyl-β-L-fucopyranosyl)tri-n-butylstannane (S20). (3,4-Di-O-benzyl-β-Lfucopyranosyl)tri-n-butylstannane 6 (617 mg, 1.00 mmol) was dissolved in anh. THF (2.00 ml), cooled to 0 C, and KHMDS (3.00 ml, 1.50 mmol, M in PhMe) was added. The reaction mixture was stirred at 0 C for 1 h. BnBr (238 μl, 2.00 mmol) was added and the reaction was allowed to warm to rt and stirred for an additional 12 h. The crude mixture was concentrated with SiO2 and purified via flash chromatography on SiO2 (Hexanes:EtOAc, 50:1) to afford S20 (660 mg, 93%) as a colorless oil: = (c = 20.0, CHCl3); IR (ATR) ν = 3067, 3033, 2925, 2873, 2854, 1458, 1070, 735, 698 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 15H), 5.15 (d, J = 11.1 Hz, 1H), 5.04 (d, J = 11.8 Hz, 1H), 4.79 (d, J = 11.6 Hz, 1H), (m, 3H), (m, 1H), 3.73 (dd, J = 3.0, 1.2 Hz, 1H), 3.59 (dd, J = 8.9, 2.8 Hz, 1H), (m, 1H), 3.32 (qd, J = 6.4, 1.1 Hz, 1H), (m, 6H), 1.30 (m, 6H), 1.18 (d, J = 6.3 Hz, 3H), (m, 15H); 13 C NMR (75 MHz, CDCl3) δ 139.3, 139.1, 138.6, 128.5, 128.3, 128.2, 127.8, (2), 127.4, 88.0, 78.3, 78.0, 77.3, 76.7, 75.2, 74.6 (2), 71.9, 29.2, 27.5, 17.5, 13.8, 9.3; HRMS (ESI) m/z calcd for C39H56O4SnNa [M + Na] , found S36

37 (2,3,4-Tri-O-benzyl-β-L-quinovopyranosyl)tri-n-butylstannane (S21). (3,4-Di-O-benzyl-β -Lquinovopyranosyl)tri-n-butylstannane 2 (750 mg, 1.21 mmol) was dissolved in anh. THF (6.00 ml), cooled to 0 C, and KHMDS (3.60 ml, 1.80 mmol, M in PhMe) was added. The reaction mixture was stirred at 0 C for 0.5 h. BnBr (285 ml, 2.40 mmol) was added and the reaction continued at 0 C for 0.5 h and rt for 12 h. The crude mixture was concentrated with SiO2 and purified via flash chromatography on SiO2 (Hexanes:EtOAc, 20:1) to yield S21 (628 mg, 86%) as a pale yellow oil: = +7.8 (c = 1.00, CHCl3); IR (ATR) ν = 3030, 2922, 1487, 1453, 1363, 1209, 1069, 729, 689, 516 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 15H), 5.07 (d, J = 11.2 Hz, 1H), 4.95 (d, J = 10.9 Hz, 1H), 4.89 (d, J = 10.9 Hz, 1H), 4.84 (d, J = 11.0 Hz, 1H), (m, 3H), (m, 1H), 3.61 (t, J = 8.3 Hz, 1H), 3.51 (d, J = 11.0 Hz, 1H), (m, 1H), (m, 6H), (m, 9H), (m, 15H); 13 C NMR (75 MHz, CDCl3) δ 138.8, 138.7, 138.5, 128.6, 128.4, 128.1, 127.9, 127.7, (2), 89.5, 85.2, 82.2, 79.3, 75.5, 75.5, 74.6, 74.4, 29.2, 27.5, 18.5, 13.8, 9.2; HRMS (ESI) m/z calcd for C39H56O4Na [M + Na] , found [2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl-(1 4)-3,6-di-O-benzyl-β-D-glucopyranosyl]tri-nbutylstannane (S22a). To a solution of hexa-o-benzyl maltal 19 (10.9 g, mmol) at 0 C, vigorously stirring biphasic solution of CH2Cl2 (20.0 ml), sat. NaHCO3 (500 ml), and acetone (20.0 ml), a solution of Oxone (18.0 g, 58.8 mmol) in H2O (75 ml) was added dropwise over 30 min. After the addition, the mixture was stirred for 0.5 h at 0 C, then for 2 h at rt. The crude reaction mixture was extracted with CH2Cl2. The combined organic phases were dried over Na2SO4 and concentrated to afford the epoxide as a white solid. The crude epoxide was dissolved in anh., degassed THF (30.0 ml) under N 2 and cooled to -45 C for the addition of MeMgSnBu3 (9.67 g, 29.4 mmol). The solution was warmed to -20 C and stirred for 2 h and quenched with H2O. The mixture was filtered through Celite and the organic phase was separated, the aqueous phase was extracted with CH2Cl2 and the combined organic layers were dried over Na2SO4 and concentrated. The crude material was purified by flash column chromatography on SiO2 (Hexanes:EtOAc, 20:1) to afford S22a ( 3.1 g, 20%) as a colorless oil: = +2.4 (c = 14.0, CHCl3); IR (ATR) ν = 3569, 3067, 3033, 2955, 2921, 2869, 1458, 1030, 735, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 28H), (m, 2H), 5.62 (d, J = 3.6 Hz, 1H), 5.06 (d, J = 11.9 Hz, 1H), 4.94 (d, J = 10.9 Hz, 1H), (m, 2H), (m, 3H), (m, 4H), 4.38 (d, J = 12.1 Hz, 1H), (m, 5H), (m, 3H), (m, 2H), (m, 3H), 3.37 (dq, J = 9.4, 1.9 Hz, 1H), 1.99 (d, J = 3.7 Hz, 1H), (m, 6H), (m, 6H), (m, 15H); 13 C NMR (75 MHz, CDCl3) δ 139.1, 139.0, 138.9, 138.6, 138.2, 138.1, 128.7, (2), 128.3, (2), 128.0, 127.9, (2), 127.6, 127.5, 127.4, 127.3, 97.3, 89.6, 83.3, 82.2, 79.9, 77.9, 75.7, 75.6, 75.1, 74.4, 74.1, 73.6, 73.5, 71.1, 69.7, 68.5, 29.2, 27.5, 13.9, 9.0; HRMS (ESI) m/z calcd for C66H84O10SnNa [M + Na] , found S37

38 [2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl-(1 4)-2,3,6-tri-O-benzyl-β-D-glucopyranosyl]tri-nbutylstannane (S22). [2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl-(1 4)-3,6-di-O-benzyl-β-Dglucopyranosyl]tri-n-butylstannane S22a (342 mg, mmol) was dissolved in anh. THF (1.50 ml), cooled to 0 C, and KHMDS (900 μl, mmol, 0.5 M in PhMe) was added. The reaction mixture was stirred at 0 C for 1 h. BnBr (71.0 μl, mmol) was added and the reaction was allowed to warm to rt and stirred for an additional 12 h. The crude mixture was concentrated with SiO2 and purified via flash chromatography on SiO2 (Hexanes:EtOAc, 20:1) to afford S22 (320 mg, 87%) as a colorless oil: = +1.5 (c = 4.00, CHCl3); IR (ATR) ν = 3089, 3067, 2955, 2925, 2873, 1074, 1033, 754, 735 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 35H), 5.66 (d, J = 3.6 Hz, 1H), 5.02 (d, J = 11.8 Hz, 1H), (m, 5H), (m, 7H), 4.31 (d, J = 12.1 Hz, 1H), 4.10 (t, J = 8.9 Hz, 1H), (m, 11H), (m, 1H), (m, 6H), (m, 6H), (m, 15H); 13 C NMR (75 MHz, CDCl3) δ (2), 138.7, 138.5, (2), (2), (2), 128.2, 128.0, 127.9, (2), 127.7, (2), (2), 127.4, 127.1, 126.6, 97.4, 89.6, 83.0, 82.3, 79.6, 78.0, 75.6, 75.1, 74.8, 74.3, 74.0, 73.9, 73.7, 73.6, 73.5, 71.0, 69.7, 68.5, 29.3, 27.6, 13.8, 9.3; HRMS (ESI) m/z calcd for C73H90O10SnNa [M + Na] , found [2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl-(1 2)-3,4-di-O-benzyl-6-O-(tert-butyldiphenylsilyl)-β-Dglucopyranosyl]tri-n-butylstannane (S23). [3,4,6-Tri-O-benzyl-β-D-glucopyranosyl-(1 2)-3,4-di-Obenzyl-6-O-(tert-butyldiphenylsilyl)-β-D-glucopyranosyl]tri-n-butylstannane 2 (190 mg, mmol) was dissolved in anh. THF (1.00 ml), cooled to 0 C, and KHMDS (350 μl, mmol, 0.5 M in PhMe) was added. The reaction mixture was stirred at 0 C for 1 h. BnBr (26.0 μl, mmol) was added and the reaction was allowed to warm to rt and stirred for an additional 12 h. The crude mixture was concentrated with SiO2 and purified via flash chromatography on SiO2 (Hexanes:EtOAc, 30:1) to afford S23 (170 mg, 83%) as a colorless oil: = (c = 4.5, CHCl3); IR (ATR) ν = 3067, 3033, 2955, 2925, 2858, 1458, 1361, 1056, 735, 698 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 4H), (m, 32H), (m, 4H), 5.12 (d, J = 7.9 Hz, 1H), 5.03 (d, J = 11.3 Hz, 1H), (m, 2H), (m, 6H), (m, 2H), 4.43 (d, J = 11.8 Hz, 1H), 4.19 (dd, J = 11.1, 8.5 Hz, 1H), (m, 6H), (m, 3H), (m, 2H), 3.17 (d, J = 9.3 Hz, 1H), (m, 6H), (m, 6H), (m, 15H), 0.85 (t, J = 7.3 Hz, 9H); 13 C NMR (75 MHz, CDCl3) δ 138.8, 138.7, 138.6, 138.5, (2), 136.0, 135.8, 133.1, (2), (2), 128.6, (2), (2), (2), 128.1, 128.0, (2), (2), 127.7, (2), 102.4, 90.2, 84.8, 84.1, 83.0, 78.6, 78.1, 77.4, 75.9, 75.6, 75.4, 75.3, 75.1, 74.5, 73.3, 69.0, 62.8, 31.1, 29.4, 27.8, 27.0, 19.4, 14.0, 9.5; HRMS (ESI) m/z calcd for C82H102O10SiSnNa [M + Na] , found S38

39 Methyl 2,3,4-tri-O-benzyl-6-S-(pyrrolidine-2,5-dione)-6-thio-α-D-glucopyranoside (S24). Methyl 6-Sacetyl-2,3,4-tri-O-benzyl-6-thio-α-D-glucopyranoside 20 (831 mg, 1.58 mmol) was dissolved in MeOH (7.50 ml) and sodium methoxide (100 μl, mmol, 25 wt % in MeOH) was added. The reaction was allowed to stir for 1 h and acidified with 1 M HCl (aq.). The crude reaction was washed twice with CH2Cl2 and the organic layers were collected, dried with Na2SO4, filtered, and concentrated. Then according to the general procedure D, to a flame-dried round bottom flask was charged N-chlorosuccinimide (222 mg, 1.66 mmol) and anhydrous CH2Cl2 (6.00 ml) under N2. The mixture was cooled to 0 C and the crude thiol in CH2Cl2 (2.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (245 μl, 1.74 mmol) in CH2Cl2 (2.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 3:2) to afford S24 (700 mg, 77%) as a white solid: = +5.6 (c = 3.50, CHCl3); IR (ATR) ν = 3067, 3033, 3014, 2929, 1730, 1152, 1074, 754 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 15H), 4.99 (d, J = 10.9 Hz, 1H), 4.93 (d, J = 11.1 Hz, 1H), (m, 2H), (m, 2H), 4.35 (d, J = 3.5 Hz, 1H), 3.97 (dd, J = 9.6, 8.8 Hz, 1H), 3.82 (ddd, J = 9.5, 6.7, 2.6 Hz, 1H), 3.62 (dd, J = 9.7, 8.7 Hz, 1H), 3.50 (dd, J = 9.7, 3.5 Hz, 1H), 3.40 (s, 3H), 3.31 (dd, J = 14.4, 2.6 Hz, 1H), 2.79 (dd, J = 14.4, 6.8 Hz, 1H), 2.65 (s, 4H); 13 C NMR (75 MHz, CDCl3) δ 176.8, 138.8, 138.3, (2), 128.5, 128.4, (3), 128.0, 127.8, 98.5, 81.9, 79.9, 79.8, 75.8, 75.2, 73.7, 70.4, 55.7, 39.3, 31.1, 28.7; HRMS (ESI) m/z calcd for C32H35NO7SNa [M + Na] , found Methyl 2,3,6-tri-O-benzyl-4-S-(pyrrolidine-2,5-dione)-4-thio-α-D-galactopyranoside (S25). According to the general procedure D, to a flame-dried round bottom flask was charged N-chlorosuccinimide (190 mg, 1.42 mmol) and anhydrous CH2Cl2 (6.00 ml) under N2. The mixture was cooled to 0 C and methyl 2,3,6-tri-Obenzyl-4-thio-α-D-glucopyranoside 9 (650 mg, 1.35 mmol) in CH2Cl2 (2.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (210 μl, 1.49 mmol) in CH2Cl2 (2.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 3:1) to afford S25 (550 mg, 71%) as a white solid: = -1.1 (c = 7.0, CHCl3); IR (ATR) ν = 3067, 3014, 2910, 1726, 1305, 1152, 1044, 750 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 13H), 4.99 (d, J = 10.9 Hz, 1H), 4.93 S39

40 (d, J = 11.1 Hz, 1H), (m, 2H), (m, 3H), (m, 1H), (m, 2H), 4.10 (dd, J = 9.9, 3.5 Hz, 1H), 3.83 (dd, J = 10.4, 5.4 Hz, 1H), 3.68 (dd, J = 10.4, 7.0 Hz, 1H), 3.37 (s, 3H), (m, 4H); 13 C NMR (75 MHz, CDCl3) δ 177.1, 138.6, 138.3, 138.1, (2), 128.5, 128.4, 128.2, 128.0, 127.9, 127.7, 99.4, 79.7, 77.1, 74.3, 74.1, 73.7, 70.2, 68.8, 55.5, 51.3, 28.5; HRMS (ESI) m/z calcd for C32H35NO7SNa [M + Na] , found Methyl 2,3,6-tri-O-benzyl-4-S-(pyrrolidine-2,5-dione)-4-thio-α-D-glucopyranoside (S26). Methyl 4-Sacetyl-2,3,6-tri-O-benzyl-4-thio-α-D-glucopyranoside 22 (850 mg, 2.05 mmol) was dissolved in MeOH (10.0 ml) and sodium methoxide (100 μl, mmol, 25 wt % in MeOH) was added. The reaction was allowed to stir for 1 h and acidified (ph 3)) with 1 M HCl (aq.). The crude reaction was washed twice with CH2Cl2 and the organic layers were collected, dried with Na2SO4, filtered, and concentrated. Then according to the general procedure D, to a flame-dried round bottom flask was charged N-chlorosuccinimide (285 mg, 2.14 mmol) and anhydrous CH2Cl2 (6.00 ml) under N2. The mixture was cooled to 0 C and the crude thiol in CH2Cl2 (2.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (316 μl, 2.25 mmol) in CH2Cl2 (2.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 3:1) to afford S26 (836 mg, 71%) as a white solid: = +1.9 (c = 5.0, CHCl3); IR (ATR) ν = 3067, 3029, 2906, 1730, 1134, 1093, 1048, 743, 702 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 13H), (m, 2H), 4.75 (d, J = 12.0 Hz, 1H), (m, 4H), 4.26 (dd, J = 11.2, 3.6 Hz, 1H), (m, 3H), 3.59 (dd, J = 9.0, 3.4 Hz, 1H), (m, 4H), (m, 4H). 13 C NMR (75 MHz, CDCl3) δ 177.3, 139.2, 138.4, 138.1, 128.6, (2), 128.3, (2), (2), 127.6, 98.2, 81.6, 77.3, 75.6, 73.7, 73.4, 69.9, 69.8, 55.6, 53.0, 28.6; HRMS (ESI) m/z calcd for C32H35NO7SNa [M + Na] , found ,3,4,6-Tetra-O-acetyl-1-S-(pyrrolidine-2,5-dione)-1-thio-β-D-glucopyranoside (S27). According to the general procedure D, to a flame-dried round bottom flask was charged N-chlorosuccinimide (60.0 mg, mmol) and anhydrous CH2Cl2 (2.00 ml) under N2. The mixture was cooled to 0 C and 2,3,4,6-tetra-O-acetyl- 1-thio-β-D-glucopyranoside (155 mg, mmol) in CH2Cl2 (1.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (67.0 μl, mmol) in CH2Cl2 (1.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 1:1) to afford S27 (70.0 mg, 35%) as a white solid: = -11 (c = 4.5, CHCl3); IR (ATR) ν = 3026, 2959, 1745, 1372, 1212, 1037, 754 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ 5.18 (t, J = 9.2 Hz, 1H), 5.05 (t, J = 9.7 Hz, 1H), 4.90 (dd, J = 10.1, 9.0 Hz, S40

41 1H), 4.68 (d, J = 10.1 Hz, 1H), 4.16 (qd, J = 12.4, 3.7 Hz, 2H), 3.65 (ddd, J = 10.0, 4.8, 2.7 Hz, 1H), 2.84 (s, 4H), 2.10 (s, 3H), 2.06 (s, 3H), 2.00 (s, 3H), 1.98 (s, 3H); 13 C NMR (75 MHz, CDCl3) δ 176.1, 170.7, 170.2, 170.0, 169.4, 86.4, 76.2, 73.8, 69.0, 68.0, 61.9, 28.7, 20.8, 20.7, 20.6; HRMS (ESI) m/z calcd for C18H23NO11SNa [M + Na] , found ,3,4,6-Tetra-O-benzoyl-S-(Pyrrolidine-2,5-dione)-1-thio-β-D-glucopyranoside (S28). According to the general procedure D, to a flame-dried round bottom flask was charged N-chlorosuccinimide (105 mg, mmol) and anhydrous CH2Cl2 (4.00 ml) under N2. The mixture was cooled to 0 C and 2,3,4,6-tetra-Obenzoyl-1-thio-β-D-glucopyranoside (490 mg, mmol) in CH2Cl2 (1.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (117 μl, mmol) in CH2Cl2 (1.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 1:1) to afford S28 (260 mg, 49%) as a white solid: = +5.9 (c = 5.0, CHCl3); IR (ATR) ν = 3070, 3018, 2957, 1730, 1268, 1097, 713 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 2H), (m, 4H), (m, 2H), (m, 1H), (m, 9H), 7.25 (m, 2H), 5.99 (dd, J = 3.3, 1.1 Hz, 1H), 5.74 (t, J = 9.9 Hz, 1H), 5.64 (dd, J = 9.9, 3.3 Hz, 1H), 5.17 (d, J = 10.0 Hz, 1H), 4.65 (dd, J = 11.3, 6.7 Hz, 1H), 4.39 (dd, J = 11.3, 6.3 Hz, 1H), (m, 1H), 2.74 (s, 4H); 13 C NMR (75 MHz, CDCl3) δ 176.1, 166.1, 165.9, 165.6, 165.5, 133.9, 133.7, 133.5, 130.2, 130.1, 129.9, 129.5, (2), (2), (2), 128.5, 86.9, 75.4, 72.6, 68.1, 67.3, 62.1, 28.7; HRMS (ESI) m/z calcd for C38H31NO11SNa [M + Na] , found (R)-Ethyl 2-((tert-butoxycarbonyl)amino)-3-((2,5-dioxopyrrolidin-1-yl)thio)propanoate (S29). According to the general procedure D, to a flame-dried round bottom flask was charged N-chlorosuccinimide (280 mg, 2.10 mmol) and anhydrous CH2Cl2 (4.00 ml) under N2. The mixture was cooled to 0 C and N-Boc- L-cysteine ethyl ester (500 mg, 2.00 mmol) in CH2Cl2 (2.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (309 μl, 2.20 mmol) in CH2Cl2 (2.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 1:1) to afford S30 (260 mg, 84%) as a white solid: = -8.7 (c = 0.40, CHCl3); IR (ATR) ν = 3298, 2985, 1692, 1374, 1160, 1026, 754 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ 5.77 (d, J = 8.5 Hz, 1H), 4.55 (s, 1H), 4.15 (q, J = 7.4 Hz, 2H), (m, 1H), 3.01 (dd, J = 15.1, 5.6 Hz, 1H), 2.78 (s, 4H), 1.43 (s, 9H), 1.27 (t, J = 7.1 Hz, 3H); 13 C NMR (75 MHz, CDCl3) δ 177.2, 80.4, 62.2, 52.7, 39.5, 28.7, 28.5, 14.2; HRMS (ESI) m/z calcd for C14H22N2O6SNa [M + Na] , found S41

42 (R)-tert-Butyl 2-((S)-2-((tert-butoxycarbonyl)amino)-3-phenylpropanamido)-3-((2,5-dioxopyrrolidin-1- yl)thio)propanoate (S30). According to the general procedure D, to a flame-dried round bottom flask was charged N-chlorosuccinimide (280 mg, 2.10 mmol) and anhydrous CH2Cl2 (4.00 ml) under N2. The mixture was cooled to 0 C and Boc-L-cysteine ethyl ester (500 mg, 2.00 mmol) in CH2Cl2 (2.00 ml) was added dropwise via syringe pump over 20 minutes. The resulting mixture was stirred for 30 minutes followed by the addition of triethylamine (309 μl, 2.20 mmol) in CH2Cl2 (2.00 ml) via syringe pump over 20 minutes. The solution was allowed to stir for an additional 30 minutes and then quenched with water. The aqueous layer was washed twice with CH2Cl2, the organic layers were collected, dried with Na2SO4, filtered, and concentrated. The crude material was purified via flash chromatography on SiO2 (Hexanes:EtOAc, 1:1) to afford S30 (260 mg, 84%) as a white solid: = (c = 5.0, CHCl3); IR (ATR) ν = 3351, 3007, 2981, 2936, 1722, 1678, 1499, 1149, 754 cm -1 ; 1 H NMR (300 MHz, CDCl3) δ (m, 5H), 5.02 (d, J = 8.3 Hz, 1H), 4.79 (s, 1H), 4.35 (td, J = 8.2, 5.4 Hz, 1H), 3.56 (dd, J = 15.2, 3.0 Hz, 1H), 3.16 (dd, J = 14.0, 5.4 Hz, 1H), 2.97 (dd, J = 14.0, 8.2 Hz, 1H), 2.87 (dd, J = 15.2, 5.3 Hz, 1H), 2.80 (s, 4H), 1.45 (s, 9H), 1.36 (s, 9H); 13 C NMR (75 MHz, CDCl3) δ 177.8, 171.5, 168.9, 155.5, 136.6, 129.5, 128.7, 127.0, 83.3, 79.9, 55.8, 51.5, 40.7, 38.6, 28.8, 28.4, 28.0; HRMS (ESI) m/z calcd for C25H35N3NaO7SNa [M + Na] , found Benzyl-4-(tri-n-butylstannyl)azetidin-2-one (S31). A solution of 4-(tri-n-butylstannyl)azetidin-2-one 23 (0.700 g, 1.94 mmol) in anhydrous THF (9.70 ml) was cooled to 0 C, and a solution of KHMDS (4.27 ml, 2.14 mmol, 0.5 M in PhMe) was added. The solution was stirred at 0 C for 0.5 h, benzyl bromide (0.431 g, 2.52 mmol) was added, and the resulting solution was stirred for additional 0.5 h at 0 C and then for 6 h at rt. The reaction mixture was concentrated and directly purified by column chromatography on SiO2 (Hexanes:EtOAc, 1:0 then 85:15) to yield S31 (0.750 g, 86%) as a light yellow oil: 1 H NMR (300 MHz, CDCl3) δ (m, 5H), 4.80 (d, J = 15.4 Hz, 1H), 3.83 (d, J = 15.4 Hz, 1H), (m, 1H), (m, 1H), (m, 1H), (m, 6H), (m, 6H), (m, 15H); 13 C NMR (75 MHz, CDCl3) δ 167.3, 136.0, 128.7, 128.0, 127.6, 46.7, 41.2, 40.4, 29.2, 29.1, 28.9, 27.8, 27.7, 27.4, 27.0 (2), 13.6, 8.9; HRMS (ESI) calcd for C22H37NOSnNa [M + Na] + : , found S42

43 Phenyl-1-thio-β-D-glucopyranoside. 10 Under N2, phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-Dglucopyranoside 10 (101.2 mg, mmol), anh. CH2Cl2 (1.60 ml) and mesitylene (0.265 ml, 1.91 mmol) were successively added into a flame dried glassware. The mixture was cooled to -78 C and BCl3 (1.27 ml, 1.27 mmol, 1.0 M in CH2Cl2) was added drop-wise over 5 min. The resulting solution was stirred at -78 C for 0.5 h, quenched by drop-wise addition of MeOH (2.0 ml) at -78 C, and allowed to stir for an additional 20 min. The resulting mixture was concentrated and directly purified by column chromatography on SiO2 (CH2Cl2:MeOH, 9:1) to afford glucopyranoside (42.2 mg, 72%) as a colorless oil: 1 H NMR (300 MHz, CD3OD) δ 7.55 (d, J = 7.2 Hz, 2H), 7.27 (qd, J = 9.9, 8.1, 4.4 Hz, 3H), 4.60 (dd, J = 9.7, 3.8 Hz, 1H), 3.86 (d, J = 12.0 Hz, 1H), 3.66 (dd, J = 12.1, 4.7 Hz, 1H), (m, 4H); 13 C NMR (75 MHz, CD3OD) δ 135.2, 132.7, (2), 128.3, 128.3, 89.4, 82.0, 79.6, 79.5, 73.7, 71.3, 62.8, Characterization data matched the literature report. 10 Phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (10). 1 According to the general protocol A, (2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)tri-n-butylstannane 2 8 (122 mg, mmol), or 1- (phenylthio)pyrrolidine-2,5-dione 9a (20.7 mg, mmol) or 1,2-diphenyldisulfane 9b (21.8 mg, mmol), and CuCl (30.0 mg, mmol) were added to anhydrous m-xylene and 1,2-dichloroethane (2:1, 3.00 ml). The reaction mixture was heated under N2 at 130 ºC for 96 h and afforded after chromatographic purification on SiO2 (Hexanes:EtOAc, 10:1) 10 without effect on the reaction yield and stereospecificity. S43

44 All DFT calculations were performed with the Gaussian 16 software package. 23 Geometry optimizations of all the minima and transition states were carried out at the B3LYP 24 level of theory with additional Grimme s D3 dispersion correction (Becke-Johnson damping) 25 using the def2-svp basis set. 26 Vibrational frequencies were computed at the same level to evaluate its zero-point vibrational energy (ZPVE) and thermal corrections at 298 K, as well as to check whether each optimized structure is a transition state or not. The single-point energies were computed at the same level of theory, combined with def2-tzvpp 27 basis set and SMD solvation model 28 for 1,4-dioxane using the optimized structures. The 3D diagrams of molecules were generated using CYLView. 29 In addition, to correct the Gibbs free energies under pressure of 1 atm to the standard state in solution (1 mol/l), a correction of RTln(cs/cg) (about 1.9 kcal/mol) is added to energies of all species. cs is the standard molar concentration in solution (1 mol/l), cg is the standard molar concentration in gas phase ( mol/l), and R is the gas constant. S44

45 S45

46 S46

47 S47

48 S48

49 S49

50 S50

51 S51

52 S52

53 S53

54 S54

55 S55

56 S56

57 S57

58 S58

59 S59

60 S60

61 S61

62 S62

63 S63

64 S64

65 S65

66 S66

67 S67

68 S68

69 S69

70 S70

71 S71

72 S72

73 S73

74 S74

75 S75

76 S76

77 S77

78 S78

79 S79

80 S80

81 S81

82 S82

83 S83

84 S84

85 S85

86 S86

87 S87

88 S88

89 S89

90 S90

91 S91

92 S92

93 S93

94 S94

95 S95

96 S96

97 S97

98 S98

99 S99

100 S100

101 S101

102 S102

103 S103

104 S104

105 S105

106 S106

107 S107

108 S108

109 S109

110 S110

111 S111

112 S112

113 S113

114 S114

115 S115

116 S116

117 S117

118 S118

119 S119

120 1. Dinkelaar, J.; de Jong, A. R.; van Meer, R.; Somers, M.; Lodder, G.; Overkleeft, H. S.; Codée, J. D.; van der Marel G. A. J. Org. Chem., 2009, 74, Zhu, F.; Rourke, M. J.; Yang, T.; Rodriguez, J.; Walczak, M. A. J. Am. Chem. Soc., 2016, 138, Li, X.; Huang, L.; Hu, X.; Huang, X. Org. Biomol. Chem., 2009, 7, Veleti, S. K.; Lindenberger, J. J.; Thanna, S.; Ronning, D. R.; Sucheck, S. J. J. Org. Chem., 2014, 79, Griffin, F. K.; Paterson, D. E.; Murphy, P. V.; Taylor, R. Eur. J. Org. Chem., 2002, 7, Kumar, A.; Schmidt, R. R. Eur. J. Org. Chem., 2012, 14, Schneider, C. C.; Manarin, F.; Panatieri, R. B.; Barros, O. S. R.; Zeni, G. J. Braz. Chem. Soc., 2010, 21, Rayner, P. J.; Gelardi, G.; O Brien, P.; Horan, R. A. J.; Blakemore, D. C. Org. Biomol. Chem., 2014, 12, Jin, Y.; Yang, H.; Fu, H. Chem. Commun., 2016, 52, Nielsen, M. M.; Stougaard, B. A.; Bols, M.; Glibstrup, E.; Pedersen, C. M. Eur. J. Org. Chem., 2017, 9, Shi, Y.; Chen, S.; Zhang, F; Chen, B. ChemistrySelect, 2018, 3, Zhu, R.; Shi, X. Synth. Comm., 2012, 42, Balgotra, S.; Verma, P.; Kour, J.; Gupta, S.; Vishwakarma, R.; Sawant, S. ChemistrySelect, 2018, 3, Savarin, C.; Srogl, J.; Liebeskind, L. S. Org. Lett., 2002, 4, Spurg, A.; Schnakenburg, G.; Waldvogel, S. R. Chem. Eur. J., 2009, 15, Maity, S.; Karmakar, U.; Samanta, R. Chem. Comm., 2017, 53, Furuya, T.; Strom, A. E.; Ritter, T. J. Am. Chem. Soc., 2009, 131, Hostier, T.; Ferey, V.; Ricci, G.; Pardo, D. G.; Cossy, J. Org. Lett., 2015, 17, Vedachalam, S.; Tan, S. M.; Teo, H. P.; Cai, S.; Liu, X. Org. Lett., 2012, 14, Weng, S.; Lin, Y.; Chen, C. Org. Lett., 2006, 8, Elhalabi, J.; Rice, K. G. Carbohydr. Res., 2001, 335, Ek, M.; Garegg, P. J.; Hultberg, H.; Oscarson, S. J. Carbohydr. Chem., 1983, 2, Nativi, C.; Ricci, A.; Taddei, M. Tetrahedron Lett., 1990, 31, Gaussian 16, Revision A.03, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, G. A. Petersson, H. Nakatsuji, X. Li, M. Caricato, A. V. Marenich, J. Bloino, B. G. Janesko, R. Gomperts, B. Mennucci, H. P. Hratchian, J. V. Ortiz, A. F. Izmaylov, J. L. Sonnenberg, D. Williams-Young, F. Ding, F. Lipparini, F. Egidi, J. Goings, B. Peng, A. Petrone, T. Henderson, D. Ranasinghe, V. G. Zakrzewski, J. Gao, N. Rega, G. Zheng, W. Liang, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, K. Throssell, J. A. Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. J. Bearpark, J. J. Heyd, E. N. Brothers, K. N. Kudin, V. N. Staroverov, T. A. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A. P. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, J. M. Millam, M. Klene, C. Adamo, R. Cammi, J. W. Ochterski, R. L. Martin, K. Morokuma, O. Farkas, J. B. Foresman, and D. J. Fox, Gaussian, Inc., Wallingford CT, (a) Becke, A. D. J. Chem. Phys. 1993, 98, (b) Lee, C.; Yang, W.; Parr, R. G. Phys. Rev. B: Condens. Matter Mater. Phys., 1988, 37, Grimme, S.; Ehrlich, S.; Goerigk, L. J. Comp. Chem., 2011, 32, Weigend, F.; Ahlrichs, R. Phys. Chem. Chem. Phys., 2005, 7, Marenich, A. V.; Cramer, C. J.; Truhlar, D. G. J. Phys. Chem. B 2009, 113, CYLview, 1.0b, C. Y. Legault, Université de Sherbrooke, 2009 ( S120

121 S121

122 S122

123 S123

124 S124

125 S125

126 S126

127 S127

128 S128

129 S129

130 S130

131 S131

132 S132

133 S133

134 S134

135 S135

136 S136

137 S137

138 S138

139 S139

140 S140

141 S141

142 S142

143 S143

144 S144

145 S145

146 S146

147 S147

148 S148

149 S149

150 S150

151 S151

152 S152

153 S153

154 S154

155 S155

156 S156

157 S157

158 S158

159 S159

160 S160

161 S161

162 S162

163 S163

164 S164

165 S165

166 S166

167 S167

168 S168

169 S169

170 S170

171 S171

172 S172

173 S173

174 S174

175 S175

176 S176

177 S177

178 S178

179 S179

180 S180

181 S181

182 S182

183 S183

184 S184

185 S185

186 S186

187 S187

188 S188

189 S189

190 S190

191 S191

192 S192

193 S193

194 S194

195 S195

196 S196

197 S197

198 S198

199 S199

200 S200

201 S201

202 S202

203 S203

204 S204

205 S205

206 S206

207 S207

208 S208

209 S209

210 S210

211 S211

212 S212

213 S213

214 S214

215 S215

216 S216

217 S217

218 S218

219 S219

220 S220

221 S221

222 S222

223 S223

224 S224

225 S225

226 S226

227 S227

228 S228

229 S229

230 S230

231 S231

232 S232

233 S233

234 S234

235 S235

236 S236

237 S237

238 S238

239 S239

240 S240

241 S241

242 S242

243 S243

244 S244

245 S245

246 S246

247 S247

248 S248

249 S249

250 S250

251 S251

252 S252

253 S253

254 S254

255 S255

256 S256

257 S257

258 S258

259 S259

260 S260

261 S261

262 S262

263 S263

264 S264

265 S265

266 S266

267 S267

268 S268

269 S269

270 S270

271 S271

272 S272

273 S273

274 S274

275 S275

276 S276

277 S277

278 S278

279 S279

280 S280

281 S281

282 S282

283 S283

284 S284

285 S285

286 S286

287 S287

288 S288

289 S289

290 S290

291 S291

292 S292

293 S293

294 S294

295 S295

296 S296

297 S297

298 S298

299 S299

300 S300

301 S301

302 S302

303 S303

304 S304

305 S305

306 S306

307 S307

308 S308

309 S309

310 S310

311 S311

312 S312

313 S313

314 S314

315 S315

316 S316

317 S317

318 S318

319 S319

320 S320

321 S321

322 S322

323 S323

324 S324

325 S325

326 S326

327 S327

328 S328

329 S329

330 S330

331 S331

332 S332

333 S333

334 S334

335 S335

336 S336

337 S337

338 S338

339 S339

340 S340

341 S341

342 S342

343 S343

344 S344

345 S345

346 S346

347 S347

348 S348

349 S349

350 S350

351 S351

352 S352

353 S353

354 S354

355 S355

356 S356

357 S357

358 S358

359 S359

360 S360

361 S361

362 S362

363 S363

364 S364

365 S365

366 S366

367 S367

368 S368

369 S369

370 S370

371 S371

372 S372

373 S373

374 S374

375 S375

376 S376

377 S377

378 S378

379 S379

380 S380

381 S381

382 S382

383 S383

384 S384

385 S385

386 S386

387 S387

388 S388

389 S389

390 S390

391 S391

392 S392

393 S393

394 S394

395 S395

396 S396

397 S397

398 S398

399 S399

400 S400

401 S401

402 S402

403 S403

404 S404

405 S405

406 S406

407 S407

408 S408

409 S409

410 S410

411 S411

Total Synthesis of Candicanoside A, a Potent Antitumor Saponin Bearing a Rearranged Steroidal Side Chain

Total Synthesis of Candicanoside A, a Potent Antitumor Saponin Bearing a Rearranged Steroidal Side Chain Total Synthesis of Lobatoside E, a Potent Antitumor Cyclic Triterpene Saponin Chunsheng Zhu, Pingping Tang, and Biao Yu* State Key Laboratory of Bio-organic and Natural Products Chemistry, Shanghai Institute

More information

Microsoft Word _File000001_ doc

Microsoft Word _File000001_ doc Chemoselective N-Heterocyclic Carbene Catalyzed Cascade of Enals with Nitroalkenes Zijun Wu, Xu Wang, Fangyi Li, Jicheng Wu, Jian Wang* Department of Pharmacology and Pharmaceutical Sciences School of

More information

Table of Contents 1. General General procedure and product characterization data for Table ,3-Dione substrates characterization da

Table of Contents 1. General General procedure and product characterization data for Table ,3-Dione substrates characterization da Supporting Information Wiley-VCH 2013 69451 Weinheim, Germany Highly Enantioselective Construction of 3-Hydroxy xindoles through a Decarboxylative Aldol Addition of Trifluoromethyl a-fluorinated gem-diols

More information

Microsoft Word - Supporting information.doc

Microsoft Word - Supporting information.doc Enantioselective Organocatalytic Michael Addition of Malonates to α, β-unsaturated Ketones Pengfei Li, Shigang Wen, Feng Yu, Qiaoxia Liu, Wenjun Li, Yongcan Wang, Xinmiao Liang, * Jinxing Ye * Dalian Institute

More information

1. General Information Unless otherwise noted, all reagents, catalysts and solvents were purchased from commercial suppliers and used without further

1. General Information Unless otherwise noted, all reagents, catalysts and solvents were purchased from commercial suppliers and used without further Supporting Information for Transformation of Alkynes into Chiral Alcohols via TfOH-Catalyzed Hydration and Ru-Catalyzed Tandem Asymmetric Hydrogenation Sensheng Liu, Huan Liu, Haifeng Zhou, *,, Qixing

More information

Microsoft Word - Supporting Information clear

Microsoft Word - Supporting Information clear Supporting Information Galanthamine, Plicamine, and Secoplicamine Alkaloids from Zephyranthes candida and Their Anti-acetylcholinesterase and Anti-inflammatory Activities Guanqun Zhan, Junfei Zhou, Rong

More information

Microsoft Word _File000004_ docx

Microsoft Word _File000004_ docx Supporting Information The Discovery of 3,3 -spiro[azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection Weihua Shi 1, Zhigan Jiang 1, Haiying He 1 *, Fubiao Xiao 1,

More information

Microsoft Word _File000001_ docx

Microsoft Word _File000001_ docx Supporting Information ph-regulated Optical Performances in Organic/Inorganic Hybrid: A Dual-Mode Sensor Array for Pattern Recognition-Based Biosensing Qing Yan, Xu-Yin Ding, Zi-Han Chen, Shi-Fan Xue,

More information

Hyperascyrones A–H, Polyprenylated Spirocyclic Acylphloroglucinol Derivatives from Hypericum ascyron Linn

Hyperascyrones A–H, Polyprenylated Spirocyclic Acylphloroglucinol Derivatives from Hypericum ascyron Linn Electronic Supplementary Material (ESI) for rganic & Biomolecular Chemistry. This journal is The Royal Society of Chemistry 2018 Supplementary Material Anti-inflammatory fusicoccane-type diterpenoids from

More information

Molecules 2017, 22, 236; doi: /molecules S1 of S21 Supplementary Materials: Bioactive Stilbenes from Cortex Mori Radicis, and Their Neur

Molecules 2017, 22, 236; doi: /molecules S1 of S21 Supplementary Materials: Bioactive Stilbenes from Cortex Mori Radicis, and Their Neur S1 of S21 Supplementary Materials: Bioactive Stilbenes from Cortex Mori Radicis, and Their Neuroprotective and Analgesic Activities Mediated by mglur1 Ya-Nan Wang, Mao-Feng Liu, Wei-Zhen Hou, Rui-Ming

More information

untitled

untitled 2502 1 (PAs)PAs WHO PAs PAs PAs (PAs) (1) (Dictionary of Natural Products) SciFinder PAs PAs (2) PubMedEFSA MHRA PAs (3) (4) (1)(3) PAs (PAs) PAs PAs Senkirkine (Symphytum officinale) PAs Retronecine PAs

More information

DOI /j.issn Food Research And Development UPLC-MS/MS 5 0.

DOI /j.issn Food Research And Development UPLC-MS/MS 5 0. 118 217 5 38 1 DOI 1.3969/j.issn.5-6521.217.1.28 Food Research And Development 1 2 1 2 1 2 1 2 1 2 1 2 1. 731 2. 731 - UPLC-MS/MS 5. 1 mol/l ProElut PXC 5 % - Thermo Hypersil Gold mm 2.1 mm 1.9 μm ESI

More information

Microsoft Word - Electronic Supplementary Information.doc

Microsoft Word - Electronic Supplementary Information.doc Electronic Supplementary Material (ESI) for RSC Advances. This journal is The Royal Society of Chemistry 2015 Electronic Supplementary Information Natural Thioredoxin Reductase Inhibitors from Jatropha

More information

Supporting information Combination of N-Arylstilbazolium Organic Nonlinear Optical Chromophores with Iodoargentates: Structural Diversities and Optica

Supporting information Combination of N-Arylstilbazolium Organic Nonlinear Optical Chromophores with Iodoargentates: Structural Diversities and Optica Supporting information Combination of N-Arylstilbazolium Organic Nonlinear Optical Chromophores with Iodoargentates: Structural Diversities and Optical Properties Yu-Kang Wang, Li-Ming Zhao, Yu-Qing Fu,

More information

Table of Contents

Table of Contents Electronic Supplementary Material (ESI) for Catalysis Science & Technology. This journal is The Royal Society of Chemistry 205 Supporting Information Novel glycosyl pyridyl-triazole@palladium nanoparticles:

More information

スライド 1

スライド 1 O-03 AFM IR -OH C=O C=C C-OH O-H C-O m Wavenumber (cm ) nisina-y@cc.okayama-u.ac.jp Height/ nm 1 0-1 (b) 0.8 nm 0.8 nm XPS (C 1s) 0 1 2 3 4 5 Position/ m AFM 50 nm XPS C-O C=O C-C Height/ nm 1 0-1 (b)

More information

Microsoft Word _File000009_ doc

Microsoft Word _File000009_ doc Supporting information Cyclizidine-type Alkaloids from the Streptomyces sp. HNA39 Yong-Jun Jiang, Jia-Qi Li, Hao-Jian Zhang, Wan-Jing Ding, and Zhong-Jun Ma * Institute of Marine Biology, Ocean College,

More information

H 2 SO ml ml 1. 0 ml C 4. 0 ml - 30 min 490 nm 0 ~ 100 μg /ml Zhao = VρN 100% 1 m V ml ρ g

H 2 SO ml ml 1. 0 ml C 4. 0 ml - 30 min 490 nm 0 ~ 100 μg /ml Zhao = VρN 100% 1 m V ml ρ g 16 6 2018 11 Chinese Journal of Bioprocess Engineering Vol. 16 No. 6 Nov. 2018 doi 10. 3969 /j. issn. 1672-3678. 2018. 06. 004 1 2 1 1 1. 330200 2. 330006 4 Box-Behnken 1 25 g /ml 121 92 min 2 6. 284%

More information

%% &% %% %% %% % () (! #! %!!!!!!!%! # %& ( % & ) +, # (.. /,) %& 0

%% &% %% %% %% % () (! #! %!!!!!!!%! # %& ( % & ) +, # (.. /,) %& 0 !! # # %% &% %% %% %% % () (! #! %!!!!!!!%! # %& ( % & ) +, # (.. /,) %& 0 +! (%& / 1! 2 %& % & 0/ / %& + (.%.%, %& % %& )& % %& ) 3, &, 5, % &. ) 4 4 4 %& / , %& ).. % # 6 /0 % &. & %& ) % %& 0.!!! %&

More information

! + +, ) % %.!&!, /! 0! 0 # ( ( # (,, # ( % 1 2 ) (, ( 4! 0 & 2 /, # # ( &

! + +, ) % %.!&!, /! 0! 0 # ( ( # (,, # ( % 1 2 ) (, ( 4! 0 & 2 /, # # ( & ! # %! &! #!! %! %! & %! &! & ( %! & #! & )! & & + ) +!!, + ! + +, ) % %.!&!, /! 0! 0 # ( ( # (,, # ( % 1 2 ) (, 3 0 1 ( 4! 0 & 2 /, # # ( 1 5 2 1 & % # # ( #! 0 ) + 4 +, 0 #,!, + 0 2 ), +! 0! 4, +! (!

More information

untitled

untitled 理 料 易 行 年 年 類 了 料 料 易 理 不 理 率 異 數 量 率 料 量 ~ ~ ~ 料 量 1 料 年 陸 不 料 年來 類 量 年 類 量 類 量 類 量 量不 量不 量不 蘭 量不 年 令 量 類 量 量 年來 力 量 降 量 料 類 年來 類 料 量 量 了 立 類 量 料 量 率 率 度 留 率 率 度 理 不 例行 立了 易 量 料 量 行 立 易 量 例行 2 料 料 料 (distilled

More information

THE APPLICATION OF ISOTOPE RATIO ANALYSIS BY INDUCTIVELY COUPLED PLASMA MASS SPECTROMETER A Dissertation Presented By Chaoyong YANG Supervisor: Prof.D

THE APPLICATION OF ISOTOPE RATIO ANALYSIS BY INDUCTIVELY COUPLED PLASMA MASS SPECTROMETER A Dissertation Presented By Chaoyong YANG Supervisor: Prof.D 10384 070302 9825042 UDC 2001.6. 2001.7. 20016 THE APPLICATION OF ISOTOPE RATIO ANALYSIS BY INDUCTIVELY COUPLED PLASMA MASS SPECTROMETER A Dissertation Presented By Chaoyong YANG Supervisor: Prof.Dr. Xiaoru

More information

g ml 10% ph 色谱条件 kinetex C μm 100 A 4. 6 mm 150 mm 25 5 μl A B 10 mmol /L ml /min

g ml 10% ph 色谱条件 kinetex C μm 100 A 4. 6 mm 150 mm 25 5 μl A B 10 mmol /L ml /min 25 4 2013 8 监测技术 5 1 2 1 ( 1. 江苏省疾病预防控制中心, 江苏南京 210009; 2. 南京医科大学第二附属医院, 江苏南京 210029) 5 Phenomenex kinetex C 18 2. 6 μm 4. 6 mm 150 mm 10 mmol /L ph 2. 5 + 60 40 DAD 280 nm 5 20. 0 mg /L ~ 100 mg /L 0.

More information

标题

标题 第 36 卷第 1 期 2016 年 1 月 环 境 科 学 学 报 Acta Scientiae Circumstantiae Vol 36 No 1 Jan 2016 DOI 10 13671 j hjkxxb 2015 0429 尚姣博 宋艳群 张媛媛 等 2016 Fe Si Al 分子印迹材料的制备及其对酸性橙 II AOII 的选择吸附性能 J 环境科学学报 36 1 185 192 Shang

More information

Microsoft Word - Lenovo_L15M3PB2 (Winbook)_3S1P_UN38.3 Test Report_SLEU

Microsoft Word - Lenovo_L15M3PB2 (Winbook)_3S1P_UN38.3 Test Report_SLEU Lithium-ion Battery UN38.3 Test Report Recommendations on the TRANSPORT OF DANGEROUS GOODS (Manual of Tests and Criteria, Fifth revised edition, Amend.2) Customer: Lenovo Model: L15M3PB2 Rating: 11.25V,

More information

Supporting Information Bipolar Electrode based Multi-Color Electrochemiluminescence Biosensor Yin-Zhu Wang, Cong-Hui Xu, Wei Zhao*, Qi-Yuan Guan, Hong

Supporting Information Bipolar Electrode based Multi-Color Electrochemiluminescence Biosensor Yin-Zhu Wang, Cong-Hui Xu, Wei Zhao*, Qi-Yuan Guan, Hong Supporting Information Bipolar Electrode based Multi-Color Electrochemiluminescence Biosensor Yin-Zhu Wang, Cong-Hui Xu, Wei Zhao*, Qi-Yuan Guan, Hong-Yuan Chen, Jing-Juan Xu* State key Laboratory of Analytical

More information

01-0982.doc

01-0982.doc 第 32 卷 第 7 期 岩 土 工 程 学 报 Vol.32 No.7 2010 年 7 月 Chinese Journal of Geotechnical Engineering July 2010 沿 海 碎 石 回 填 地 基 上 高 能 级 强 夯 系 列 试 验 对 比 研 究 年 廷 凯 1,2, 水 伟 厚 3, 李 鸿 江 4, 杨 庆 1,2, 王 玉 立 (1. 大 连 理 工

More information

: 307, [], [2],,,, [3] (Response Surface Methodology, RSA),,, [4,5] Design-Expert 6.0,,,, [6] VPJ33 ph 3,, ph, OD, Design-Expert 6.0 Box-Behnken, VPJ3

: 307, [], [2],,,, [3] (Response Surface Methodology, RSA),,, [4,5] Design-Expert 6.0,,,, [6] VPJ33 ph 3,, ph, OD, Design-Expert 6.0 Box-Behnken, VPJ3 微 生 物 学 通 报 FEB 20, 2008, 35(2) 306~30 Microbiology 2008 by Institute of Microbiology, CAS tongbao@im.ac.cn 生 物 实 验 室 响 应 面 分 析 法 优 化 副 溶 血 性 弧 菌 生 长 条 件 刘 代 新 宁 喜 斌 * 张 继 伦 2 (. 200090) (2. 20202) 摘 要

More information

.., + +, +, +, +, +, +,! # # % ( % ( / 0!% ( %! %! % # (!) %!%! # (!!# % ) # (!! # )! % +,! ) ) &.. 1. # % 1 ) 2 % 2 1 #% %! ( & # +! %, %. #( # ( 1 (

.., + +, +, +, +, +, +,! # # % ( % ( / 0!% ( %! %! % # (!) %!%! # (!!# % ) # (!! # )! % +,! ) ) &.. 1. # % 1 ) 2 % 2 1 #% %! ( & # +! %, %. #( # ( 1 ( ! # %! % &! # %#!! #! %!% &! # (!! # )! %!! ) &!! +!( ), ( .., + +, +, +, +, +, +,! # # % ( % ( / 0!% ( %! %! % # (!) %!%! # (!!# % ) # (!! # )! % +,! ) ) &.. 1. # % 1 ) 2 % 2 1 #% %! ( & # +! %, %. #(

More information

# % & ) ) & + %,!# & + #. / / & ) 0 / 1! 2

# % & ) ) & + %,!# & + #. / / & ) 0 / 1! 2 !!! #! # % & ) ) & + %,!# & + #. / / & ) 0 / 1! 2 % ) 1 1 3 1 4 5 % #! 2! 1,!!! /+, +!& 2! 2! / # / 6 2 6 3 1 2 4 # / &!/ % ). 1!!! &! & 7 2 7! 7 6 7 3 & 1 2 % # ) / / 8 2 6,!!! /+, +! & 2 9! 3 1!! % %

More information

Microsoft PowerPoint - ryz_030708_pwo.ppt

Microsoft PowerPoint - ryz_030708_pwo.ppt Long Term Recovery of Seven PWO Crystals Ren-yuan Zhu California Institute of Technology CMS ECAL Week, CERN Introduction 20 endcap and 5 barrel PWO crystals went through (1) thermal annealing at 200 o

More information

[1] Nielsen [2]. Richardson [3] Baldock [4] 0.22 mm 0.32 mm Richardson Zaki. [5-6] mm [7] 1 mm. [8] [9] 5 mm 50 mm [10] [11] [12] -- 40% 50%

[1] Nielsen [2]. Richardson [3] Baldock [4] 0.22 mm 0.32 mm Richardson Zaki. [5-6] mm [7] 1 mm. [8] [9] 5 mm 50 mm [10] [11] [12] -- 40% 50% 38 2 2016 4 -- 1,2, 100190, 100083 065007 -- 0.25 mm 2.0 mm d 10 = 0.044 mm 640 3 300. Richardson--Zaki,,, O359 A doi 10.6052/1000-0879-15-230 EXPERIMENTAL STUDY OF FLUID-SOLID TWO-PHASE FLOW IN A VERTICAL

More information

Microsoft Word - molecules supple.docx

Microsoft Word - molecules supple.docx Supporting Information Secondary Metabolites from the Marine-Derived Fungus Dichotomomyces sp. L-8 and Their Cytotoxic Activity Li-Hong Huang 1,2, Yan-Xiu Chen 1,2, Jian-Chen Yu 3, Jie Yuan 3, Hou-Jin

More information

, GC/MS ph GC/MS I

, GC/MS ph GC/MS I S00017052 O O , GC/MS ph GC/MS I Abstract Drug abuse is a serious issue throughout the world. Amphetamine-type stimulants (ATS) are substances frequently used by drug abusers. There are significant needs

More information

㈠ 1. (Olympus BX51) (Evolution/QImaging Digital Camera kit) 2. ( G A E R r o t a r y microtome) 3. (Forma Scientific 6512 Vaccum Oven)

㈠ 1. (Olympus BX51) (Evolution/QImaging Digital Camera kit) 2. ( G A E R r o t a r y microtome) 3. (Forma Scientific 6512 Vaccum Oven) . 1 : 289-298 2010 Ann. Rept. Food Drug Res. 1 : 289-298 2010 289 (Panax ginseng C. A. Meyer) (Panax quinquefolium L.) 46 47 PCR-DNA 46 23 9 (39%) 24 2 (8%)47 77% 23 Acquity BEH C 18 2.1 mm 100 mm 1.7

More information

动物学

动物学 2007 5 1 2 2..2 3..3 4..4 5 6 6..12 1...15 1 1 1 2 3 4 2 1 2 3 4 1 2 1 1 2 3 1% 4 70% 5 0.05 0.2% 6 2 2 1 7 10% 3 5% 2 0.3 5% 3 70 80% 4 5 90% 40% 9 1 80% 70% 6 40% 15 5 1 12 24 70% 70% 7 70% 2% 1 2 3

More information

05Cv1.mps

05Cv1.mps 第 三 章 皮 肤 病 的 防 治 和 护 理 学 习 要 点 皮 肤 病 的 预 防 不 同 的 皮 肤 病 要 采 取 相 应 的 预 防 措 施, 多 数 皮 肤 病 要 通 过 去 除 病 因, 避 免 诱 发 因 素, 切 断 传 播 途 径 等 措 施 来 预 防 皮 肤 病 的 治 疗 了 解 内 服 药 物 的 适 应 证 和 不 良 反 应, 掌 握 外 用 药 物 的 性 能 和

More information

32

32 32 H.V 50mm Gas in Gas out 260mm 15mm H.V 37mm 0.5mm Vis Sample setting 33 UV Light emission spectra of oxygen and air plasmas. Intensity (arb.units) 70000 60000 50000 40000 30000 20000 10000 Air, 60 Pa

More information

果葡糖浆中5-HMF生成影响因素及其去除方法

果葡糖浆中5-HMF生成影响因素及其去除方法 Journal of Advances in Physical Chemistry 物 理 化 学 进 展, 2013, 2, 27-32 http://dx.doi.org/10.12677/japc.2013.23005 Published Online August 2013 (http://www.hanspub.org/journal/japc.html) Influencing Factors

More information

GC-APPI-MasCom

GC-APPI-MasCom GC-APPI Interface MasCom Technologies Founded in January 1991 as MasCom Analysengeräte Service GmbH Office at Sophie-Germain-Str. 4, 281 Bremen, Germany 18 Employees 6 Electronic engineers 4 Precision

More information

29 0. 0.1 0.2 0.3 1. 30 1840 1930 1932 1926 35 51 55 214 1 31 1988 3 2. 2.1 3 2000 2.2 79 1 52 32 56 57 57 2 2.3. 2 10 4 40 16 4 64 2.4 3. 3.0 3.1 1 Hz 33 193ms 176 174 169 167 165 163 162 160 159 (T )

More information

HJ HJ/T HBC The technical requirement for environmental labeling products Water based coatings

HJ HJ/T HBC The technical requirement for environmental labeling products Water based coatings HJ HJ/T 201 2005 HBC 12 2002 The technical requirement for environmental labeling products Water based coatings 2005 11 22 2006 01 01 ... III 1... 2... 3... 4... 5... 6... A ( )... B ( ) VOC... 8 C ( )...

More information

檢 舉 獎 金, 分 別 於 檢 察 官 提 起 公 訴 不 起 訴 處 分 緩 起 訴 處 分 或 經 法 院 判 決 有 罪 確 定 後, 由 受 理 檢 舉 機 關 通 知 檢 舉 人 親 自 具 名 領 取 檢 舉 人 有 數 人 時, 獎 金 平 均 分 配 ; 其 有 先 後 者, 獎

檢 舉 獎 金, 分 別 於 檢 察 官 提 起 公 訴 不 起 訴 處 分 緩 起 訴 處 分 或 經 法 院 判 決 有 罪 確 定 後, 由 受 理 檢 舉 機 關 通 知 檢 舉 人 親 自 具 名 領 取 檢 舉 人 有 數 人 時, 獎 金 平 均 分 配 ; 其 有 先 後 者, 獎 農 業 環 保 篇 法 規 行 政 院 農 業 委 員 會 令 中 華 民 國 100 年 9 月 15 日 農 防 字 第 1001479569 號 修 正 檢 舉 走 私 進 口 動 植 物 及 其 產 品 獎 勵 辦 法 第 七 條 第 七 條 之 一 第 九 條 之 一 附 修 正 檢 舉 走 私 進 口 動 植 物 及 其 產 品 獎 勵 辦 法 第 七 條 第 七 條 之 一 第 九 條

More information

卡尔费休库仑滴定仪和水蒸发器测量卡氏炉标准物质

卡尔费休库仑滴定仪和水蒸发器测量卡氏炉标准物质 Certificate of Ana lysis Apura Certified Reference Material Producer: Accreditation: Description of CRM: Lot No.: Composition: Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany. Merck KGaA, Darmstadt,

More information

Microsoft Word - 20130316-148_editing.doc

Microsoft Word - 20130316-148_editing.doc 国 内 外 食 用 色 素 标 准 的 比 较 及 检 测 方 法 的 研 究 进 展 宋 丹 萍 1 张 宏 1.2* 李 琪 2.3 (1. 四 川 师 范 大 学 化 学 与 材 料 科 学 学 院, 四 川 成 都 市 610068;2. 四 川 师 范 大 学 生 命 科 学 院, 四 川 成 都 市 610068;3. 四 川 师 范 大 学 植 物 资 源 开 发 与 应 用 研 究

More information

Microsoft Word - 8 期中文目次.doc

Microsoft Word - 8 期中文目次.doc 中 草 药 Chinese Traditional and Herbal Drugs 第 44 卷 第 8 期 2013 年 4 月 989 养 阴 清 肺 糖 浆 指 纹 图 谱 研 究 1, 姜 姗 2, 冯 丽 君 2, 孔 慧 2, 曲 昌 海 2, 尹 兴 斌 2, 倪 健 1. 北 京 中 医 药 大 学 教 务 处, 北 京 100029 2. 北 京 中 医 药 大 学 中 药 学

More information

Yamasaki et al_Supporting Information_JOC_revised

Yamasaki et al_Supporting Information_JOC_revised Supporting Information Structure-Reactivity Relationship of Piperidine Nitroxide: Electrochemical, ESR and Computational Studies Toshihide Yamasaki a, Fumiya Mito a, Yuko Ito a, Sokkar Pandian b, Yuichi

More information

2 ( 自 然 科 学 版 ) 第 20 卷 波 ). 这 种 压 缩 波 空 气 必 然 有 一 部 分 要 绕 流 到 车 身 两 端 的 环 状 空 间 中, 形 成 与 列 车 运 行 方 向 相 反 的 空 气 流 动. 在 列 车 尾 部, 会 产 生 低 于 大 气 压 的 空 气 流

2 ( 自 然 科 学 版 ) 第 20 卷 波 ). 这 种 压 缩 波 空 气 必 然 有 一 部 分 要 绕 流 到 车 身 两 端 的 环 状 空 间 中, 形 成 与 列 车 运 行 方 向 相 反 的 空 气 流 动. 在 列 车 尾 部, 会 产 生 低 于 大 气 压 的 空 气 流 第 20 卷 第 3 期 2014 年 6 月 ( 自 然 科 学 版 ) JOURNAL OF SHANGHAI UNIVERSITY (NATURAL SCIENCE) Vol. 20 No. 3 June 2014 DOI: 10.3969/j.issn.1007-2861.2013.07.031 基 于 FLUENT 测 轨 道 交 通 隧 道 中 电 波 折 射 率 结 构 常 数 张 永

More information

14-0390-0696.doc

14-0390-0696.doc 390 药 学 学 报 Acta Pharmaceutica Sinica 2013, 48 (3): 390 394 HPLC-MS/MS 法 定 量 研 究 比 格 犬 灌 胃 替 诺 福 韦 酯 后 替 诺 福 韦 血 浆 药 代 动 力 学 * 王 宝 莲, 扈 金 萍, 盛 莉, 陈 晖, 李 燕 ( 中 国 医 学 科 学 院 北 京 协 和 医 学 院 药 物 研 究 所, 北 京 100050)

More information

Ps22Pdf

Ps22Pdf mm Hg kpa mm Hg kpa mmh g kpa mmh g mmh g kpa kpa mmhg kpa mm Hg E M E E kpa mmhg kpa mmhg kpa mmh g mm H g mmh g kpa mmhg kpa mmh g kpa mmhg Schmieder Scherrer Montfans Perloff mg g a kpa

More information

2007 5 1

2007 5 1 2007 5 1 2 1.1 1.1.1 1. 2. 3. 4. 5. 1.1.2 1. 1 2 3 4 5 1 2 3 2. 1 2 3 3 4 3. 1 2 3 1.1.3 1. 2. 3. 3% 5% 2% 4. 5. 30 1.2 1.2.1 1.4 1.4(1) 1.4(2) ( ) 1.4(3) 1.2.2 1.6 ( ) 1.6(1) 1.6(2) 1.6(3) ( ) 1.6(3)

More information

广 州 蓝 皮 书 社 会 保 障 关 键 词 : 广 州 社 会 保 障 社 会 保 险 社 会 救 助 社 会 福 利 社 会 保 障 体 系 由 社 会 救 助 社 会 保 险 社 会 福 利 住 房 保 障 四 大 系 统 以 及 慈 善 事 业 和 其 他 补 充 保 险 构 成 在 主

广 州 蓝 皮 书 社 会 保 障 关 键 词 : 广 州 社 会 保 障 社 会 保 险 社 会 救 助 社 会 福 利 社 会 保 障 体 系 由 社 会 救 助 社 会 保 险 社 会 福 利 住 房 保 障 四 大 系 统 以 及 慈 善 事 业 和 其 他 补 充 保 险 构 成 在 主 2013 年 广 州 社 会 保 障 发 展 报 告 总 报 告 General Report 1 2013 年 广 州 社 会 保 障 发 展 报 告 广 州 市 社 会 科 学 院 课 题 组 摘 要 : 广 州 社 会 保 障 在 覆 盖 面 保 障 水 平 保 障 体 系 建 设 领 域 取 得 明 显 进 展 本 报 告 通 过 分 析 广 州 社 会 保 障 发 展 的 现 状, 指 出

More information

931-33FR-E 1,2,3,4- BTCA DP60 931-33 FR-E BTCA DP60 143.0 177.4 173.7 137.4 141.6 140.3 144.0 119.3 X- DP60 Ea 90.988kJ/mol 99.793kJ/mol lna 20.898 22

931-33FR-E 1,2,3,4- BTCA DP60 931-33 FR-E BTCA DP60 143.0 177.4 173.7 137.4 141.6 140.3 144.0 119.3 X- DP60 Ea 90.988kJ/mol 99.793kJ/mol lna 20.898 22 2005 Research of Crease-Resistant Finishing on Natural Bamboo Fabric 2005 5 931-33FR-E 1,2,3,4- BTCA DP60 931-33 FR-E BTCA DP60 143.0 177.4 173.7 137.4 141.6 140.3 144.0 119.3 X- DP60 Ea 90.988kJ/mol 99.793kJ/mol

More information

岛津LC应用系统

岛津LC应用系统 Access to your success SHIMADZU Access to your success SHIMADZU Access to your success SHIMADZU Access to your success SHIMADZU Co-Sense for BA Co-Sense for BA + LCMS Access to your success SHIMADZU Access

More information

30期

30期 中 国 农 学 通 报 2014,30(30):285-289 Chinese Agricultural Science Bulletin 傅 里 叶 变 换 红 外 光 谱 法 在 橄 榄 油 掺 假 鉴 别 中 的 应 用 黄 秀 丽, 黄 飞, 曾 宪 远, 宁 焕 焱, 唐 丽 娜, 奉 夏 平 ( 广 东 省 惠 州 市 质 量 计 量 监 督 检 测 所, 广 东 惠 州 516003)

More information

Microsoft Word - Lenovo_L14M4P23 (Y51)_4S1P_UN38.3 Test Report_SLEU

Microsoft Word - Lenovo_L14M4P23 (Y51)_4S1P_UN38.3 Test Report_SLEU Lithium-ion Battery UN38.3 Test Report Recommendations on the TRANSPORT OF DANGEROUS GOODS (Manual of Tests and Criteria, Fifth revised edition, Amend 1) Customer: Lenovo Model: L14M4P23 Rating: 14.8V,

More information

1

1 1 C 2 C 3 + 3 C C 3 DMC) C 3 C 3 C n C 2 C 3 DPC) C 3 A,, 2009, 51 (5), 336 341. 2 CD,DVD) C S ' ' ' C ' ' n 2 2 ' ' ' 3 Cl Cl + + C 2 catalyst 4 + C 2 catalyst Sakai, T.; Tsutsumi, Y.; Ema, T. Green Chem.

More information

1 13 1. 2. 2 1 H NMR 谱 的 测 定 1 H NMR 20 6 VARIAN INOVA - 400 MHz 7 [9] 1. 2. 3 相 溶 解 度 法 测 定 < 0. 01 mm MTX 15 3 Q 7 5 10 15 20 25 mg 20 ~ 30 mm β - 1

1 13 1. 2. 2 1 H NMR 谱 的 测 定 1 H NMR 20 6 VARIAN INOVA - 400 MHz 7 [9] 1. 2. 3 相 溶 解 度 法 测 定 < 0. 01 mm MTX 15 3 Q 7 5 10 15 20 25 mg 20 ~ 30 mm β - 1 32 1 12 ~ 16 2013 Journal of Mountain Agriculture and Biology * 黄 英 1, 马 艳 辉 2, 王 娟 2, 陶 朱 2, 薛 赛 凤 2 2, 祝 黔 江 1. 550025 2. 550025 以 七 元 瓜 环 为 主 体, 抗 癌 药 物 甲 氨 蝶 呤 为 客 体, 利 用 1 H NMR 技 术 和 紫 外 可 见 吸 收

More information

Microsoft Word - 4期中文目次.doc

Microsoft Word - 4期中文目次.doc 中 草 药 Chinese Traditional and Herbal Drugs 第 45 卷 第 4 期 2014 年 2 月 509 UPLC-MS/MS 法 快 速 检 测 减 肥 类 保 健 品 中 13 种 非 法 添 加 化 学 成 分 朱 健, 裘 一 婧, 沈 国 芳 杭 州 市 食 品 药 品 检 验 研 究 院, 浙 江 杭 州 310017 摘 要 : 目 的 建 立 保

More information

18 A B S 17.44±1() ±6.26( ) 54.23±5.5( ) 6.42±1.51() m 30m t α =.05 ( )AB 1 5 (p>.05)( )AB 1 5 (p<.05)( )A (p>.05)( )B (p<.05)( )A B

18 A B S 17.44±1() ±6.26( ) 54.23±5.5( ) 6.42±1.51() m 30m t α =.05 ( )AB 1 5 (p>.05)( )AB 1 5 (p<.05)( )A (p>.05)( )B (p<.05)( )A B The Effect of Different Training Method on Quick Coordination ability in High School Female Soccer Players 18 A B S 17.44±1() 161.39±6.26( ) 54.23±5.5( ) 6.42±1.51() 15 60-90 30m 30m t α =.05 ( )AB 1 5

More information

) & ( +,! (# ) +. + / & 6!!!.! (!,! (! & 7 6!. 8 / ! (! & 0 6! (9 & 2 7 6!! 3 : ; 5 7 6! ) % (. ()

) & ( +,! (# ) +. + / & 6!!!.! (!,! (! & 7 6!. 8 / ! (! & 0 6! (9 & 2 7 6!! 3 : ; 5 7 6! ) % (. () ! # % & & &! # % &! ( &! # )! ) & ( +,! (# ) +. + / 0 1 2 3 4 4 5 & 6!!!.! (!,! (! & 7 6!. 8 / 6 7 6 8! (! & 0 6! (9 & 2 7 6!! 3 : ; 5 7 6! ) % (. () , 4 / 7!# + 6 7 1 1 1 0 7!.. 6 1 1 2 1 3

More information

382 25,,, 4.2 g 96% m.p.139~140 ( [21] :138~139 ), (4- )-2,2 6,2 - (L), [17], 2.5 mmol 1-(2- )-, 2.5 mmol 1-(2- )-(4- ) -1-2,2 6,2 (25.0 mmol),

382 25,,, 4.2 g 96% m.p.139~140 ( [21] :138~139 ), (4- )-2,2 6,2 - (L), [17], 2.5 mmol 1-(2- )-, 2.5 mmol 1-(2- )-(4- ) -1-2,2 6,2 (25.0 mmol), 25 3 2009 3 CHINESE JOURNAL OF INORGANIC CHEMISTRY Vol.25 No.3 381~385 4-1 *,1 1 1,2 ( 1, 361005) ( 2, 361005) : -2,2 6,2 -,4 - -2,2 6,2 - (L), L (ZnL),, ZnL 1 1 2 1 2 1,ZnL : ; 4 - -2,2 6,2 - ; ; : O614.24

More information

untitled

untitled 1-1 1-2 1-3 1-4 1-5 1-6 1-7 1-8 1-9 SI SI 1-1 (science) (chemistry) (observation)(evaluation) (experimentation) (description) (hypothesis) 1. 2. 3. (phase)(solid phase) (liquid phase)(phase change) (information)(data)

More information

Microsoft Word - 3098-3102 20150611007-蔡伟江-二校

Microsoft Word - 3098-3102 20150611007-蔡伟江-二校 6 8 Vol. 6 No. 8 2015 8 Journal of Food Safety and Quality Aug., 2015 蔡 伟 江 *, 邓 鹏 飞, 刘 光 兰, 李 丹 (, 519040) 摘 要 : 目 的, 方 法 (4.6 mm 250 mm, 5.0 μm) ; : : : =70: 16: 14(V:V:V),, : 1.0 ml/min; : 40 ; : 10

More information

中 文 摘 要 芦 荟 和 金 银 花 抗 菌 成 分 提 取 及 其 对 棉 织 物 的 整 理 中 文 摘 要 随 着 生 活 水 平 的 提 高 和 健 康 环 保 意 识 的 增 强, 人 们 对 棉 织 物 卫 生 保 健 功 能 的 要 求 越 来 越 高, 故 对 棉 织 物 进 行

中 文 摘 要 芦 荟 和 金 银 花 抗 菌 成 分 提 取 及 其 对 棉 织 物 的 整 理 中 文 摘 要 随 着 生 活 水 平 的 提 高 和 健 康 环 保 意 识 的 增 强, 人 们 对 棉 织 物 卫 生 保 健 功 能 的 要 求 越 来 越 高, 故 对 棉 织 物 进 行 高 等 学 校 教 师 硕 士 学 位 论 文 (2008 届 ) 芦 荟 和 金 银 花 抗 菌 成 分 提 取 及 其 对 棉 织 物 的 整 理 Extraction of Aloe and Honey Suckle Antibacterial Ingredients and Application to Antibiotic Finishing of Cotton 研 究 生 姓 名 指 导

More information

天 然 水 製 造 水 對 於 肌 膚 非 常 重 要, 所 以 護 膚 品 中 都 含 大 量 水 份 無 印 良 品 的 護 膚 系 列 講 究 用 水, 發 現 於 日 本 東 北 深 山 洞 穴 中 的 岩 石, 其 中 所 抽 取 出 來 的 天 然 水 粒 子 細 小, 能 讓 皮 膚

天 然 水 製 造 水 對 於 肌 膚 非 常 重 要, 所 以 護 膚 品 中 都 含 大 量 水 份 無 印 良 品 的 護 膚 系 列 講 究 用 水, 發 現 於 日 本 東 北 深 山 洞 穴 中 的 岩 石, 其 中 所 抽 取 出 來 的 天 然 水 粒 子 細 小, 能 讓 皮 膚 天 然 水 製 造 水 對 於 肌 膚 非 常 重 要, 所 以 護 膚 品 中 都 含 大 量 水 份 無 印 良 品 的 護 膚 系 列 講 究 用 水, 發 現 於 日 本 東 北 深 山 洞 穴 中 的 岩 石, 其 中 所 抽 取 出 來 的 天 然 水 粒 子 細 小, 能 讓 皮 膚 迅 速 吸 收, 賦 予 肌 膚 水 潤 亮 澤 1 2 植 物 精 華 滋 潤 肌 膚 肌 膚 質

More information

ph ph ph Langmuir mg /g Al 2 O 3 ph 7. 0 ~ 9. 0 ph HCO - 3 CO 2-3 PO mg /L 5 p

ph ph ph Langmuir mg /g Al 2 O 3 ph 7. 0 ~ 9. 0 ph HCO - 3 CO 2-3 PO mg /L 5 p 1 2 1 2 3 1 2 1. 100054 2. 100054 3. 100036 ph ph ph Langmuir 166. 67 mg /g Al 2 O 3 ph 7. 0 ~ 9. 0 ph HCO - 4 5. 00 mg /L 5 ph doi 10. 13928 /j. cnki. wrahe. 2017. 03. 017 TV213. 4 + TU991. 26 + 6 A 1000-0860

More information

1. 請 先 檢 查 包 裝 內 容 物 AC750 多 模 式 無 線 分 享 器 安 裝 指 南 安 裝 指 南 CD 光 碟 BR-6208AC 電 源 供 應 器 網 路 線 2. 將 設 備 接 上 電 源, 即 可 使 用 智 慧 型 無 線 裝 置 進 行 設 定 A. 接 上 電 源

1. 請 先 檢 查 包 裝 內 容 物 AC750 多 模 式 無 線 分 享 器 安 裝 指 南 安 裝 指 南 CD 光 碟 BR-6208AC 電 源 供 應 器 網 路 線 2. 將 設 備 接 上 電 源, 即 可 使 用 智 慧 型 無 線 裝 置 進 行 設 定 A. 接 上 電 源 1. 請 先 檢 查 包 裝 內 容 物 AC750 多 模 式 無 線 分 享 器 安 裝 指 南 安 裝 指 南 CD 光 碟 BR-6208AC 電 源 供 應 器 網 路 線 2. 將 設 備 接 上 電 源, 即 可 使 用 智 慧 型 無 線 裝 置 進 行 設 定 A. 接 上 電 源 B. 啟 用 智 慧 型 裝 置 的 無 線 Wi-Fi C. 選 擇 無 線 網 路 名 稱 "edimax.setup"

More information

5-25袁宏钧.indd

5-25袁宏钧.indd 第 24 卷 第 5 期 2015 年 5 月 碘 131 doi:10.3978/j.issn.1005-6947.2015.05.005 http://dx.doi.org/10.3978/j.issn.1005-6947.2015.05.005 Chinese Journal of General Surgery, 2015, 24(5):643 647. Chinese Journal of

More information

材 料 与 方 法 仪 器 ACQUITY UPLC Xevo TQ-S 三 重 四 级 杆 液 质 联 用 仪 ( 美 国 Waters 公 司 ); 电 喷 雾 离 子 源 (ESI), Masslynx 4.1 数 据 处 理 系 统 (Waters);Thermo 低 温 离 心 机 ;KQ

材 料 与 方 法 仪 器 ACQUITY UPLC Xevo TQ-S 三 重 四 级 杆 液 质 联 用 仪 ( 美 国 Waters 公 司 ); 电 喷 雾 离 子 源 (ESI), Masslynx 4.1 数 据 处 理 系 统 (Waters);Thermo 低 温 离 心 机 ;KQ [ 应 用 纪 要 ] Rapid identification of 5 illegal additives in slimming health food by Xevo TQ-S 郝 刚 苏 州 市 食 品 药 品 检 验 所, 苏 州 15104 关 键 词 超 高 效 液 相 色 谱 - 质 谱, 多 反 应 监 测, 减 肥 类 保 健 食 品 非 法 添 加, 快 速 定 性 定 量

More information

無 印 良 品 護 膚 概 念 護 膚 產 品 應 以 素 材 安 全 性 及 功 效 為 首 要 考 慮 無 印 良 品 選 用 天 然 滋 潤 成 分 和 天 然 水, 再 加 上 其 他 補 濕 滋 潤 的 功 能 成 分, 製 造 出 適 合 日 常 使 用, 而 價 錢 合 理 的 護 膚

無 印 良 品 護 膚 概 念 護 膚 產 品 應 以 素 材 安 全 性 及 功 效 為 首 要 考 慮 無 印 良 品 選 用 天 然 滋 潤 成 分 和 天 然 水, 再 加 上 其 他 補 濕 滋 潤 的 功 能 成 分, 製 造 出 適 合 日 常 使 用, 而 價 錢 合 理 的 護 膚 無 印 良 品 護 膚 概 念 護 膚 產 品 應 以 素 材 安 全 性 及 功 效 為 首 要 考 慮 無 印 良 品 選 用 天 然 滋 潤 成 分 和 天 然 水, 再 加 上 其 他 補 濕 滋 潤 的 功 能 成 分, 製 造 出 適 合 日 常 使 用, 而 價 錢 合 理 的 護 膚 品 天 然 水 使 用 取 自 日 本 深 山 洞 穴 的 天 然 水, 水 分 粒 子 細 小,

More information

标题

标题 第 33 卷 第 6 期 钢 摇 铁 摇 钒 摇 钛 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 2012 年 12 月 IRON STEEL VANADIUM TITANIUM 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 Vol 郾 33,No 郾 6 December 2012 配 碳 比 对 TiO 2 真 空 碳 热 还 原 的 影 响 周 玉 昌 ( 攀 钢 集 团 研 究 院 有 限

More information

电 话 随 访 对 初 产 妇 产 褥 期 母 乳 喂 养 行 为 及 意 向 的 影 响 The effect of telephone follow-up on breastfeeding behaviors and intentions of new mothers during the po

电 话 随 访 对 初 产 妇 产 褥 期 母 乳 喂 养 行 为 及 意 向 的 影 响 The effect of telephone follow-up on breastfeeding behaviors and intentions of new mothers during the po ( 医 学 部 ) 在 职 人 员 申 请 硕 士 学 位 论 文 论 文 题 目 : 电 话 随 访 对 初 产 妇 产 褥 期 母 乳 喂 养 行 为 及 意 向 的 影 响 学 院 ( 医 院 所 ): 北 京 大 学 护 理 学 院 学 科 专 业 : 护 理 学 申 请 人 姓 名 : 导 师 姓 名 职 称 : 陆 虹 副 教 授 完 成 时 间 : 二 O 一 O 年 五 月 电 话

More information

Microsoft PowerPoint - ATF2015.ppt [相容模式]

Microsoft PowerPoint - ATF2015.ppt [相容模式] Improving the Video Totalized Method of Stopwatch Calibration Samuel C.K. Ko, Aaron Y.K. Yan and Henry C.K. Ma The Government of Hong Kong Special Administrative Region (SCL) 31 Oct 2015 1 Contents Introduction

More information

公衛學院新進人員-實驗室說明手冊

公衛學院新進人員-實驗室說明手冊 台 大 醫 學 院 生 化 分 生 所 新 進 人 員 - 實 驗 室 環 境 保 護 暨 職 業 安 全 衛 生 說 明 1010713 目 錄 壹 醫 學 院 生 化 分 生 所 環 境 保 護 暨 職 業 安 全 衛 生 小 組 組 織 架 構 ------------1 貳 生 化 分 生 所 實 驗 室 平 面 圖 及 逃 生 路 線 圖 --------------------------2~5

More information

Microsoft Word - 15-2014-2387.doc

Microsoft Word - 15-2014-2387.doc 第 32 卷 第 3 期 2015 年 09 月 波 谱 学 杂 志 Chinese Journal of Magnetic Resonance Vol. 32 o. 3 Sep. 2015 文 章 编 号 :1000-4556(2015)03-542-09 doi:10.11938/cjmr20150315 富 马 酸 替 诺 福 韦 二 吡 呋 酯 波 谱 数 据 与 结 构 确 证 宋 爱 华

More information

“先污染、后治理”是太湖、滇池治污失败的根本原因

“先污染、后治理”是太湖、滇池治污失败的根本原因 606791 csqyang@ntu.edu.sg 1% 表 1, 我 国 有 污 染 问 题 的 主 要 湖 泊 一 览 表 湖 泊 开 关 () 1% 8 9 10 11 17 Strategy of Remediation Follows Pollution Causes Pollution out of Control in Lakes Shu-Qing Yang

More information

13期

13期 中 国 农 学 通 报,9():- Chinese Agricultural Science Bulletin 药 百 合 种 子 萌 发 及 染 色 体 倍 性 检 测 吴 昀, 马 怡 迪, 张 琳, 夏 宜 平 ( 浙 江 大 学 农 业 与 生 物 技 术 学 院 园 艺 系 / 农 业 部 园 艺 植 物 生 长 发 育 与 品 质 调 控 重 点 开 放 实 验 室, 杭 州 ) 摘 要

More information

Microsoft Word - ED-774.docx

Microsoft Word - ED-774.docx journal.newcenturyscience.com/index.php/gjanp Global Journal of Advanced Nursing Practice,214,Vol.1,No.1 The practicality of an improved method of intravenous infusion exhaust specialized in operating

More information

WATER PURIFICATION TECHNOLOGY April 5th, 0.4 TiO TiO UV-0PC UNICO [0] TiO TiO TiO HNO 00 W TiO TiO TiO >40 nm TiO 0 ml 0 mg / L -. TiO 6 ml 40 ml 60 m

WATER PURIFICATION TECHNOLOGY April 5th, 0.4 TiO TiO UV-0PC UNICO [0] TiO TiO TiO HNO 00 W TiO TiO TiO >40 nm TiO 0 ml 0 mg / L -. TiO 6 ml 40 ml 60 m 0 0 50-54 Water Vol. Purification 0, No. Technology, 0,,. 50090. 0040 TiO TiO TiO + [] + + TiO TiO TiO TiO TiO TiO TiO TiO TU99 B 009-077 0 0-0050-05 Degradation of Methyl Orange with Metal Ion Modified

More information

Microsoft Word - HC20138_2010.doc

Microsoft Word - HC20138_2010.doc Page: 1 of 7 Date: April 26, 2010 WINMATE COMMUNICATION INC. 9 F, NO. 111-6, SHING-DE RD., SAN-CHUNG CITY, TAIPEI, TAIWAN, R.O.C. The following merchandise was submitted and identified by the vendor as:

More information

Epson

Epson WH / MS CMP0087-00 TC WH/MS EPSON EPSON EXCEED YOUR VISION EXCEED YOUR VISION Seiko Corporation Microsoft and Windows are registered trademarks of Microsoft Corporation. Mac and Mac OS are registered trademarks

More information

地下水監測井現地水質試驗

地下水監測井現地水質試驗 (mg/l) ppm (µg/l) ppb 1 /2,000 1 /2,000,000 1 cm/10 km 1 ppm 1 /2 1 /1,300 1 m 2 /10 1 /100,000 1 ppb 1 /32 1 /5 1 m 2 /10000 1 cm/10,000 km 1 /100,000,000 Class TDS (mg/l) Fresh Brackish Saline Brine

More information

一 学 校 基 本 情 况 目 录 二 部 门 预 算 报 表 ( 一 ) 收 支 总 表 ( 二 ) 收 入 总 表 ( 三 ) 支 出 总 表 ( 四 ) 财 政 拨 款 支 出 表 三 部 门 预 算 报 表 说 明 ( 一 ) 收 支 总 表 说 明 ( 二 ) 收 入 总 表 说 明 (

一 学 校 基 本 情 况 目 录 二 部 门 预 算 报 表 ( 一 ) 收 支 总 表 ( 二 ) 收 入 总 表 ( 三 ) 支 出 总 表 ( 四 ) 财 政 拨 款 支 出 表 三 部 门 预 算 报 表 说 明 ( 一 ) 收 支 总 表 说 明 ( 二 ) 收 入 总 表 说 明 ( 浙 江 大 学 2016 年 部 门 预 算 2016 年 5 月 1 一 学 校 基 本 情 况 目 录 二 部 门 预 算 报 表 ( 一 ) 收 支 总 表 ( 二 ) 收 入 总 表 ( 三 ) 支 出 总 表 ( 四 ) 财 政 拨 款 支 出 表 三 部 门 预 算 报 表 说 明 ( 一 ) 收 支 总 表 说 明 ( 二 ) 收 入 总 表 说 明 ( 三 ) 支 出 总 表 说 明

More information

目 录 一 学 校 基 本 情 况 二 2016 年 预 算 报 表 ( 一 ) 中 南 大 学 收 支 预 算 总 表 ( 二 ) 中 南 大 学 收 入 预 算 表 ( 三 ) 中 南 大 学 支 出 预 算 表 ( 四 ) 中 南 大 学 财 政 拨 款 支 出 预 算 表 三 2016 年

目 录 一 学 校 基 本 情 况 二 2016 年 预 算 报 表 ( 一 ) 中 南 大 学 收 支 预 算 总 表 ( 二 ) 中 南 大 学 收 入 预 算 表 ( 三 ) 中 南 大 学 支 出 预 算 表 ( 四 ) 中 南 大 学 财 政 拨 款 支 出 预 算 表 三 2016 年 中 南 大 学 2016 年 部 门 预 算 二 一 六 年 五 月 1 目 录 一 学 校 基 本 情 况 二 2016 年 预 算 报 表 ( 一 ) 中 南 大 学 收 支 预 算 总 表 ( 二 ) 中 南 大 学 收 入 预 算 表 ( 三 ) 中 南 大 学 支 出 预 算 表 ( 四 ) 中 南 大 学 财 政 拨 款 支 出 预 算 表 三 2016 年 预 算 情 况 说 明 (

More information

信息参考

信息参考 内 部 资 料 注 意 保 密 信 息 参 考 2016 年 第 1 期 ( 总 第 26 期 ) 党 政 办 公 室 编 2016 年 2 月 29 日 工 作 要 点 教 育 部 2016 年 工 作 要 点 (1) 中 共 北 京 市 委 教 育 工 作 委 员 会 北 京 市 教 育 委 员 会 北 京 市 人 民 政 府 教 育 督 导 室 2015 年 工 作 要 点 (10) 中 共

More information

Microsoft Word - 15dbtb007

Microsoft Word - 15dbtb007 第 7 期 中 共 浙 江 大 学 委 员 会 办 公 室 2015 年 12 月 16 日 按 :2015 年 12 月 15 日, 学 校 召 开 了 2015 年 党 建 工 作 会 议, 党 委 书 记 金 德 水 同 志 作 出 重 要 讲 话, 深 刻 分 析 了 学 校 改 革 发 展 面 临 的 形 势, 对 加 强 和 改 进 学 校 党 的 建 设 进 行 了 部 署, 对 充

More information

现代天文学7.ppt

现代天文学7.ppt 1983 1983 1 H 1 He 4 C 12 O 16 1 2 6 8 X A Z 2 19 α β γ F ( g) = Gmm' / d 2 F ( e) = qq' / d 2 F( e) / F( g) = 2.3 10 39 1919 α, 1930 α Be 3 4 6 6 4 4.0291 4.0015 0.0276 E=mc 2 4.12 10

More information

mm ~

mm ~ 16 3 2011 6 Vol 16 No 3 JOURNAL OF HARBIN UNIVERSITY OF SCIENCE AND TECHNOLOGY Jun 2011 1 2 3 1 150040 2 150040 3 450052 1 3 4 > 1 ~ 3 > > U414 A 1007-2683 2011 03-0121- 06 Shrinkage Characteristics of

More information

untitled

untitled . 2. 3. 4. 5. 6. 7. 8. 9. 0.. 2. 3. 4. () (2) (3) (4) (5). 2. 3. 4.. 2. 30 3. 50% 2 4. 5 5. 6. 3 7. 0 5. (desiccator) 2. (weighing bottle) 3. (erlenmeyer flask) 4. (beaker) 5. (graduated cylinder measuring

More information

% %! # % & ( ) % # + # # % # # & & % ( #,. %

% %! # % & ( ) % # + # # % # # & & % ( #,. % !!! # #! # % & % %! # % & ( ) % # + # # % # # & & % ( #,. % , ( /0 ) %, + ( 1 ( 2 ) + %, ( 3, ( 123 % & # %, &% % #, % ( ) + & &% & ( & 4 ( & # 4 % #, #, ( ) + % 4 % & &, & & # / / % %, &% ! # #! # # #

More information

2 :XYZ-2 213, I = n FCV (, F :, C, V : ), H + Na + ( ),H +, 2,,, ( ) ( ) :, 1 ;, ( Fig 1 Diagram of the electrochemical ), H +, suppressor 1) Suppress

2 :XYZ-2 213, I = n FCV (, F :, C, V : ), H + Na + ( ),H +, 2,,, ( ) ( ) :, 1 ;, ( Fig 1 Diagram of the electrochemical ), H +, suppressor 1) Suppress 5 2 1999 5 EL ECTROCHEMISTR Y Vol 5 No 2 May 1999 XYZ-2 3 ( 361005), 99 98 %, 10 %, (c v < 2),, [1 ] 1986 ( ES) ( :85 1 02998 1) [2 3,, ] [4 ], :,, 1986 XYZ-1 ( ),,, XYZ-1 :1,, 2,,,, XYZ-2, 15 5, ABS,,

More information

72 (2001) group waves. Key words: Correlation coefficient for consecutive wave heights, mean run length (1993) (1996) (1998) (1999) (1993) (

72 (2001) group waves. Key words: Correlation coefficient for consecutive wave heights, mean run length (1993) (1996) (1998) (1999) (1993) ( (2001) 1 1 71-82 71 1 2 3 1. chtsai@mail.ntou.edu.tw 2. 3. hsiang@mail.ihmt.gov.tw 1998 9 500 (mean run length) Group waves and dangerous waves at the coast Tsai Cheng-Han Lin Yin-Chern Tseng Hsiang-Mao

More information

乙 二 胺 四 乙 酸 二 钠 是 一 种 常 用 的 稳 定 剂, 常 作 为 注 射 剂 的 辅 料 使 用, 由 于 其 可 与 钙 离 子 结 合 成 可 溶 的 络 合 物 引 起 钙 的 减 少, 静 脉 制 剂 中 使 用 乙 二 胺 四 乙 酸 二 钠 (EDTA-2Na) 会 导

乙 二 胺 四 乙 酸 二 钠 是 一 种 常 用 的 稳 定 剂, 常 作 为 注 射 剂 的 辅 料 使 用, 由 于 其 可 与 钙 离 子 结 合 成 可 溶 的 络 合 物 引 起 钙 的 减 少, 静 脉 制 剂 中 使 用 乙 二 胺 四 乙 酸 二 钠 (EDTA-2Na) 会 导 [ 应 用 纪 要 ] UPLC-DAD-QTOF-MS 联 用 技 术 检 测 硫 酸 庆 大 霉 素 注 射 液 中 非 法 添 加 的 乙 二 胺 四 乙 酸 二 钠 Determination of Disodium Edetate Illegally Added in Gentamycin Sulfate injection by UPLC-DAD-QTOF-MS 1 1 1 2 袁 华

More information

: 913mol/ L LiBr ; PVA PVA, u 2 + Kl K p = 1015 = ( ), WFX2F2 115 ( ) ESR ( ) ESR J ES2FE 1 XGX 116 ( ) 10 5,37

: 913mol/ L LiBr ; PVA PVA, u 2 + Kl K p = 1015 = ( ), WFX2F2 115 ( ) ESR ( ) ESR J ES2FE 1 XGX 116 ( ) 10 5,37 4 1998 8 http://wwwpapereducn No 4 ATA PL YMERIA SIN IA Aug,1998 3 ( ) (( 310027) 3 3 310033) ( ( 386) 310033) ( ) ( ESR) ( ) :( ) ( ),( ),,,ESR, [1, ],, : Ag + u 2 + Zn 2 +, ;, Ag + [2 ] ( Silk Fibroin)

More information

218 台灣文學研究學報 第五期 一般論文 結構的當時 作為一個企圖和日語本位主義文化擴張進行抵抗 扭轉不均衡文化流向的批判性知識社群 以民間文學整理作為鏈 接的契機 以學院資源取得合法關鍵 不計採取民族文學遺產 化 知識化的柔軟姿態 開拓創作與言論空間 林荊南等人的努 力具有不可漠視的文化價值與啟

218 台灣文學研究學報 第五期 一般論文 結構的當時 作為一個企圖和日語本位主義文化擴張進行抵抗 扭轉不均衡文化流向的批判性知識社群 以民間文學整理作為鏈 接的契機 以學院資源取得合法關鍵 不計採取民族文學遺產 化 知識化的柔軟姿態 開拓創作與言論空間 林荊南等人的努 力具有不可漠視的文化價值與啟 台灣文學研究學報第五期 2007年10月 頁217-258 國立台灣文學館 文化遺產與知識鬥爭[ ] 戰爭期漢文現代文學雜誌 南國文藝 的創刊 柳書琴 清華大學台灣文學研究所助理教授 摘要 1937年7月台灣報刊廢止漢文欄 漢文文學雜誌紛紛停刊 然而 就在1941年12月1日 大東亞戰爭爆發前一週 台北市日 新町意外發行了一份帶有重建純文學理想的漢文雜誌 南國 文藝 何以一份漢文純文學雜誌得以在太平洋戰爭前夕

More information

164 藥物食品檢驗局調查研究年報 Ann. Rept. BFDA ѐణᖌ ڰ ᎇȰ7-dehydrocholesterolȱ ᆢғન D2Ȱergocalciferolȱ ഝ ف ᎇ Ȱergosterolȱ 圖一 維生素 D 之結構 ᆢғન D3Ȱcholecalciferolȱ კ ǵᆢғન!

164 藥物食品檢驗局調查研究年報 Ann. Rept. BFDA ѐణᖌ ڰ ᎇȰ7-dehydrocholesterolȱ ᆢғન D2Ȱergocalciferolȱ ഝ ف ᎇ Ȱergosterolȱ 圖一 維生素 D 之結構 ᆢғન D3Ȱcholecalciferolȱ კ ǵᆢғન! 163 藥物食品檢驗局調查研究年報. 2 : 163-170 2007 Ann Rept. BFDA Taiwan R.O.C. 2 : 163-170 2007 膳食補充品中維生素D及鈣含量標示符合性之調查 董靜馨 龔浩瑄 陳宛秋 潘志寬 周薰修 第四組 摘 要 本計畫於9年7至8月於台北市 台中市及高雄市之藥房抽購膳食補充品檢體3件 分別以高效 液相層析儀檢測維生素D含量 以火焰式原子吸收光譜儀

More information